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CHAPTER 1 
 INTRODUCTION  
Cancer is a disease characterized by uncontrolled growth and spread of 
abnormal cells. If the spread is not restricted, it can produce death. The common 
threat in all known cancers is the acquirement of abnormalities in the genetic 
material of the malignant cells in progeny. 
A tumor growth may be benign (not cancerous) or malignant (cancerous). A 
benign tumor may grow superior, but it does not extend to other parts of the body. It 
may cause serious problems, an obstruction or appear unusual, but  generally can be 
removed and does not grow back. A malignant tumor is cancerous and invades 
nearby parts of the body. It can extend to other parts of the body forming new 
tumors (metastasis), the cells growing absolutely out of control. 
Cancer may distress people at all ages. Even foetuses are at the threat, but the 
more common varieties of cancer tend to increase with age1. In the United States and 
other developed countries, malignancy is presently responsible for about 25% of all 
deaths2. On a yearly basis, 0.5% of the population is diagnosed with cancer disease. 
CAUSES  
Cancer is produced by both external factors (chemicals, tobacco, infectious 
organisms and radiation) and internal factors (hormones, inherited mutations, 
mutations from metabolism and immune conditions)3,4. The role of genetic factors 
and environmental factors towards malignancy is 5-10% and 90-95% respectively.  
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TYPES OF CANCER 
v  Adult cancers 
 Lung cancer, colorectal cancer, bladder cancer, prostate cancer, ovarian 
cancer, leukemia, breast cancer, cutaneous melanoma and non-hodgkins lymphoma. 
v  Infancy cancers 
Lymphomas, Wilm’s tumor, rhabdomyosarcoma, retinoblastoma, teratoma, 
oesteosarcoma and Ewing’s sarcoma. 
Common Symptoms 
v  Local symptoms 
 Swelling, haemorrhages, unusual lymphs or pain, jaundice and ulcer.   
v  Metastasis Symptoms  
 Hepatomegaly, enlarged lymph nodes, cough, severe pain in bones and 
hemoptysis. 
v  Systemic symptoms 
 Poor appetite, loss of weight, hormonal changes, excessive sweating and 
thrombosis. 
EHRLICH ASCITES CARCINOMA (EAC) 
EAC is one of the experimental breast cancer derived from spontaneous 
mouse adenocarcinoma. Intraperitoneal injection of the tumor emulsion induces 
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ascites5. Similar to other tumors developing in body cavities, EAC cells fill up the 
peritoneal cavity by rapid splitting up. During this fast increase, besides the tumor 
cells, accumulation of a fluid named as ascitic fluid is also observed. On the 14th day 
of i.p injection of EAC cells, almost all experimental animals showed a moderate to 
marked abdominal distention. At this occasion there are large and small solid tumors 
in the abdominal wall, peritoneal area of the liver, diaphragm, spleen, retroperitoneal 
space, intestine, around the pancreas, pelvic cavity and metastases in lungs. 
With  the  growth  of  the  tumors,  the  quantity  of  the  fluid  increases  and  as  a  
consequence, due to the pressure induced by both cancer cells and the ascitic fluid,  
produce damage to the organism, animals die  following 17-18 days of EAC 
transplantation6,7. 
Management of Cancer  
Surgery, radiation therapy, immunotherapy, chemotherapy and monoclonal 
antibody therapy were used for the treatment of cancer. The selection of therapy 
depends on the location and status of the tumor and the stage of8 the disease, as well 
as the general state of the cancer patient. Complete deletion of the cancer without 
harm to the rest of the body is the goal of treatment of malignancy9.  
1. Surgery 
The advanced stage cancer is cured by surgery, but recurrence is possible. 
Staging is a major determinant of diagnosis and requirement for adjuvant therapy. 
Infrequently, surgery is necessary to control symptoms, such as bowel obstruction or 
spinalcord compression.  
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2. Radiation therapy (RT) 
 In this therapy the cancer cells are destroyed by ionizing radiation. It can be 
executed by external beam radiotherapy (EBRT) or placing of radioactive implants 
directly into the cancer tissue. The effects of RT is localized and confined to the 
region being treated. This therapy affecting cells in the region being treated (“target 
tissue”) by destroys their genetic matter, making it impossible for these cells to 
continue to grow and divide10. Both the cancer cells and normal cells are damaged in 
RT. The aim of RT is to damage as many tumor cells as possible, while control the 
damage to nearby healthy tissue. Hence, it is given in many fractions, allowing 
healthy tissue to recover between fractions. RT may be used to treat almost every 
category of solid tumor, including cancer of the breast, brain, cervix, lung, larynx, 
skin,  pancreas,  prostate,  uterus,  stomach  or  soft  tissue  sarcomas.  It  is  also  used  to  
treat lymphoma and leukemia11. 
3. Targeted therapy 
This therapy deregulate the protein of cancer cell. Small molecule targeted 
therapy drugs generally inhibit enzymatic domains on mutated and critical proteins 
within the cancer cell. Ex: anti-HER2/new antibody trastuzumab herceptin used in 
the treatment of breast cancer and anti-CD20 antibody rituximab used  in various B-
cell malignancies.  
Photodynamic therapy (PDT) is a ternary treatment for malignancy involving 
a photosensitizer, light (often using lasers) and tissue oxygen. PDT is useful in 
removing traces of cancerous tissue after the removal of large tumors by surgery12. 
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4. Immunotherapy 
It  refers  to  a  diverse  set  of  remedial  strategies  designed  to  induce  immune  
system to fight the tumor, current methods include intravesical BCG immunotherapy 
in superficial bladder cancer and use of interferon to induce an immune response in 
melanoma and renal cell carcinoma patients12.  
5. Hormonal  Therapy 
The  hormones  inhibit  the  growth  of  certain  cancers.  Common  examples  of  
hormone-sensitive tumors include breast and prostate cancers. Removing or 
blocking estrogen or testosterones is often an important additional treatment. In 
certain cancers, administration of hormone agonists such as progesterone may be 
therapeutically beneficial. 
6.        Chemotherapy 
Chemotherapy  is the management of cancer with anticancer drugs. These agents 
are directly interfering with cell division pathway.  Most forms of chemotherapy 
target13 on all rapidly dividing cells and not specific for cancer cells (example: 
Cyclophosphamide, cisplatin). Although some degree of specificity may come from 
the inability of many cancer cells to repair DNA damage, while normal cells 
generally can. Hence, chemotherapy has the potential to harm healthy tissue, 
especially those tissues that have a high replacement rate (e.g., intestinal lining). 
These cells usually repair themselves after chemotherapy. Chemotherapeutic drugs 
are divided in to: antimetabolites, alkylating agents, plant alkaloids, anthracyclines, 
topoisomerase inhibitors, and other anti neoplastic agents. Cell division or DNA 
synthesis is affected by these drugs and have unique functions.  
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Ø  Alkylating agents 
These  agents  destroy  the  cancerous  cells  DNA  directly  and  they  are  not  
phase-specific; in other words, work in all stages of cell cycle. These agents damage 
the bone marrow and cause acute leukemia in a dose dependent manner.  Examples 
of alkylating agents are nitrogen mustards, alkyl sulfonates, nitrosoureas, 
ethylenimines and triazines. The platinum derived drugs are sometimes combined 
with alkylating agents because they kill cancer cells in a similar method.  
Ø Antimetabolites 
These  agents  damage  cells  during  the  S  phase,  interfering  the  synthesis  of  
DNA and RNA. Antimetabolites were used for the management of various cancers, 
but it causes severe toxicity to normal cells too. Examples of antimetabolites include 
5-fluorouracil (5-FU), Capecitabine, 6-meracaptopurine (6-MP), methotrexate, 
gemcitabine, cytarabine, and fludarabine. 
Ø Anti-tumor antibiotics  
v  Anthracyclines 
These agents interfere with DNA replication process. These work in all 
phases of the cell cycle. Thus, they are widely used in various types of cancers. In 
higher dose it produced permanent heart damage. Examples of anthracyclines 
include daunorubicin, doxorubicin,  ditrisarucin B and aclacinomycin A. 
Mitoxantrone is an anticancer antibiotic and similar to doxorubicin in many ways 
including  the potential for damaging the heart. This drug also acts as a  
topoisomerase II inhibitor and can lead to treatment related to leukemia. It is used to 
cure breast cancer, prostate cancer, leukemia and lymphoma. 
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v Topoisomerase inhibitors 
Topoisomerase II inhibitors  block  the topoisomerase enzyme, which helps to 
separate the strands of DNA so they can be copied. The topoisomerase II inhibitors 
are used for management of leukemias, ovarian, lung  and gastrointestinal cancers. 
Example of topoisomerase I inhibitors (topotecan and irinotecan) and 
topoisomerace II inhibitors (etoposide, mitoxantrone and teniposide) increase the 
danger of secondary cancer acute myelogenous leukemia. 
v  Mitotic inhibitors  
The mitotic inhibitors are obtained from medicinal plants. Mitotic inhibitors 
include  paclitaxel,  docetaxel and ixabepilone. It can stop mitosis or inhibit enzymes 
from making proteins needed for cell reproduction. These are working in the cell 
cycle at M phase, but can affect the cell in all phases. Mitotic inhibitors are used to 
treat many types of cancer disease including lung, breast, myelomas, leukemias, 
lymphomas and also cause peripheral nerve damage, which is a dose-limiting 
adverse effect.  
v  Corticosteroids 
Steroids and steroidal analogues are useful for the management of 
lymphoma, leukemias and multiple myeloma. When these drugs are used to kill 
cancer cells or slow their growth, they are considered as chemotherapy drugs. The 
chemotherapy induced nausea and vomiting is prevented by corticosteroids. 
Examples include methylprednisolone and dexamethasone. 
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Side effects of Chemotherapy 
Most of the chemotherapeutic agents have been reported to exhibit cytotoxic 
effect in normal cells, accompanied by undesirable side effects which include 
constipation or diarrhoea, nausea and vomiting, anemia, memory loss, malnutrition 
and immune system suppression. Infections and sepsis, secondary neoplasm, 
hemorrhage, cardiotoxicity, ototoxicity, nephrotoxicity, hepatotoxicity and death are 
other side effects caused by potential anti tumor agents. Moreover these agents are 
highly expensive, mutagenic and carcinogenic. Therefore, substitutes of the 
conservative chemotherapeutic drugs to control the high mortality rate are needed 
which will be highly useful at non-toxic doses and economical and accessible to 
general people14. This can be achieved by screening of new molecules or natural 
agents with antitumor activity.  Reports revealed that the plant-derived extracts 
containing antioxidant principles showed cytotoxicity towards tumor cells15. 
Majority of the disease conditions including cancer can be effectively treated by 
using medicinal plants having antioxidant property16. 
Despite advances in understanding the molecular basis, diagnosis and 
treatment of this fatal disease over the past decades, this malignancy remains 
elusive. Therefore, the identification of new and efficient anticancer drugs has 
always been a focal point in cancer research17, 18. 
ANTIOXIDANTS 
A free radical is a highly reactive molecule or molecular fragment that 
contains one or more unpaired electrons in its outer orbit and is capable of 
independent existence. Free radicals are generally of two types: “reactive oxygen 
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species,” (ROS) and “reactive nitrogen species” (RNS). Reactive oxygen species 
(ROS) are involved in a variety of important pathophysiological conditions 
including mutagenesis and carcinogenesis. Free radicals play an important role in 
tumor promotion by direct chemical reaction or alteration of cellular metabolic 
processes, and their scavengers (SOD, CAT, etc) represent inhibitors at different 
stages of carcinogenesis. The enzymes are found in cyotosolic and mitochondrial 
functions mainly involved in the biotransformation and detoxification of 
carcinogens. The continuing severity and magnitude of the cancer problems make it 
imperative to develop chemopreventive strategies utilizing natural antioxidants to 
block the initiation or arrest, or reverse the progression of pre-malignant cells. 
Antioxidants may protect against the toxicity of reactive oxygen species (ROS) by 
the prevention of ROS formation and neutralization of oxygen-free radicals19. 
During the last decade, there has been an escalation of interest in the role of 
antioxidants in health care and diseases. Antioxidants act as free radical inhibitors 
and thus found to play significant protective role against oxidative stress in a 
variety of diseases such as liver cirrhosis20, inflammation, diabetes, 
atherosclerosis21, cancer22, neurodegenerative disease23, nephrotoxicity and also the 
aging process24. 
Antioxidants have the potential to prevent these oxidative damages and 
thereby minimize the homeostatic disturbances, by interfering with the oxidation 
process by reacting with free radicals, chelating catalytic metals or by acting as 
oxygen scavengers25. Commonly used  antioxidants are Butylated hydroxy anisole 
(BHA), Butylated hydroxy Toluene (BHT) and propyl gallate. However, some of 
these agents are now-a-days, being suspected for liver damage and 
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carcinogenesis26,27. Therefore there is a growing interest in finding naturally 
occurring potential antioxidants, especially from plant origin. Studies to date have 
shown that various common fruits and vegetables contain different promising 
antioxidant  compounds  such  as  Vitamin  E,  Vitamin  C,  Carotenoids  as  well  as  
flavonoids, tannins and other polyphenolic constituents28, 29. 
Despite the latest development in medical sciences and progress in strategies 
of cancer treatment, cancer currently remains a tragic disease and is one of the 
major causes of death worldwide. The principal methods of cancer treatment 
include chemotherapy, radiotherapy and surgery. Chemotherapy is a universal 
systemic treatment, to which the whole body is exposed. Among the most 
successful chemotherapeutic agent are Cisplatin, Mitomycin and Docetaxel. All of 
these agents enhance serious side effects or long term complication30-32. These side 
effects include hearing loose, kidney damage, liver damage, lower blood count, 
nerve damage and blood vessel damages33, 34. 
External beams of RT are associated with unacceptably high levels of local-
regional toxicity34. Particularly, it affects the rapidly dividing cells of mucosa, 
causing irritative urinary and blood loss. Later toxic effects result from damage to 
the more slowly proliferating cells such as fibroblasts, endothelial, or paranchymal 
stem cells causing chronic fibrosis and vascular damage. Other undesired side 
effects such as immune suppression, lung fibrosis, bone necrosis and skin 
devascularization are seen with all types of conventional therapies35. 
Plants are the chief source of natural products that are used in medicine. 
Even Aspirin, the world best known and most universally used medication, has its 
Chapter 1        Introduction 
11 
natural origins from the glycoside salicin which is found in many species of the 
plant genera Salix and Populus36. 
The scientific literature is rich in epidemiological studies that support 
significant differences in the occurrence of cancers between oriental and occidental 
populations37.  Generally,  populations  that  consume  a  high  level  of  natural  herbal  
products have a reduced incidence of cancer. An example is the low incidence of 
colon cancer in Asian countries with high consumption of soyabean products. 
Soyabeans are the major dietary source of saponins, which have been suggested as 
possible anticancer agents38. 
There is lately a great interest in screening of plants for cancer prevention 
and treatment. The review of literature revealed that the whole plant of Polycarpaea 
corymbosa. Lamk was used in Indian traditional medicinal system in inflammatory 
swellings and in the treatment of jaundice39,40, liver diseases41, antimicrobial 
activity42, identification of stigmastanol43 and flavonoids44. The literature review 
has  shown  that  anticancer  activity  has  not  been  carried  on  the  whole  plant  of  
Polycarpaea corymbosa. Lamk and hence it was selected for the present 
investigation. 
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 CHAPTER 2  
AIM AND OBJECTIVE OF THE STUDY 
 
Natural products from medicinal plants are found to be safe and effective. 
Many plant species have been used in folkloric medicine to treat various ailments. 
The objective of this study is to identify a suitable plant with anticancer activity and 
screen the chosen plant for anticancer activity.   
There are several plants rich in phytoconstituents having potential 
antioxidant activity. Out of these Polycarpaea corymbosa belonging to 
Caryophyllaceae family is a plant which is easily available in south India. The 
preliminary review of literature indicates that this plant is rich in antioxidant 
phytochemicals. The whole plant of Polycarpaea corymbosa also  has  a  traditional  
and folklore claim of anticancer activity. 
Hence the aim and objective of this study is to perform a thorough literature 
review of this plant to verify whether any scientific data is available on this plant for 
its anticancer activity and then to evaluate the plant for anticancer activity by in vitro 
and in vivo methods. It is also aimed to isolate the phytoconstituents from the active 
extract and screen them for in vitro cytotoxicity, antioxidant and anticancer 
activities. 
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CHAPTER 3 
REVIEW OF LITERATURE 
The literature review comprises information on some medicinal plants that 
have been reported to exhibit anticancer activity and also covers various 
phytochemical and pharmacological studies on the whole plant of Polycarpaea 
corymbosa. 
MEDICINAL PLANTS WITH ANTICANCER POTENTIAL 
The isolation of the vinca alkaloids, vinblastine and vincristine from the 
Madagascar periwinkle, Catharanthus roseus   introduced  a  new era  of  the  use  of  
plant  material  as  anti  tumour  agents.  They  were  the  first  agents  used  clinically  for  
the treatment of cancer. Vinblastine and vincristine are primarily used in 
combination with other drugs 45. 
 Another drug from the natural source used in treatment of cancer was 
paclitaxel (taxol – Taxus brevifolia Nutt.) and used against ovarian cancer, breast 
cancer and lung cancer 46, 47. 
Camptothecin, isolated from the Camptotheca acuminate Decn (Chinese 
ornamental tree), NCI was used in clinical trials in the 1970s, but it was dropped for 
the reason of serious bladder toxicity 48.  
Topotecan and irinotecan are semi-synthetic plant derivatives of 
camptothecin and used for the treatment of ovarian and lung cancer and colorectal 
neoplasm respectively 49.  
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Etoposide and teniposide are two semi-synthetic herbal derivatives of 
epipodophyllotoxin and are used in the treatment of lymphomas, bronchial and 
testicular cancers50.  
Another plant-derived agent in clinical use is Homoharringtonine, isolated 
from the Chinese tree Cephalotaxus harringtonia var.  A  racemic  mixture  of  
harringtonine and homoharringtonine has been used successfully in China for the 
therapy of chronic and acute myelogenous leukemia 51. 
Elliptinium, a derivative of ellipticine, isolated from a Fijian medicinal plant 
Bleekeria vitensis A.C. Sm., is marketed in France for breast cancer treatment52. 
The antitumor activity of RC-18, isolated from Rubia cordifolia was 
repetitively tested on spectrum of experimental murine cancer, viz. P388, B16 
melanoma, L1210, L5178Y, sarcoma 180 and Lewis lung carcinoma. RC 18 
produced significant increase in life span of ascites leukemia P388, L1210, L5178Y 
and solid tumor B16 melanoma. However, it is unsuccessful to show any inhibitory 
action on solid tumour, lung carcinoma and sarcoma180. Promising results against a 
spectrum of experimental cancer suggest that RC-18 may show the way to develop a 
prospective anticancer agent53, 54. 
Purified fractions of methanolic extract of Centella asiatica (100µg/ml) 
showed 100% cytotoxicity to tumor cell lines (DAC and EAC cell lines) after 3h 
incubation at 37°C.  Acetone  fraction  (3.5  &  8µg/ml)  inhibited  the  proliferation  of  
mouse lung fibroblast cells were  reported55. 
The hydro alcoholic extract of Andrographis paniculata has been 
investigated for chemo preventive potential at the dose of 50 and 180mg/kg/day for 
14 days. It was found to possessed anticarcinogenic activity56. 
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The neem leaves (ethanolic extract) on oral administration treated the 
DMBA induced hamster buccal pouch carcinogenesis as revealed by the absence of 
neoplasm. These results suggest that chemo preventive effect of neem leaves may be 
mediated by induction of apoptosis57. 
The extract of curcumin can interfere the cell growth cycle of A549 cell and 
produce concentration dependent suppress of cell growth and induced cell apoptosis. 
After treated with different concentrations of curcumin the cell proliferation was 
obviously suppressed .The IC50value was 18µmol/L using linear regression 58. 
The methanol and aqueous extract of Aesculus indica and its purified fraction 
has good cytotoxic potential against breast cell lines (MCF-7). Inhibited cell 
viability action was dose dependent manner 59. 
One of the most popular beverages Camellia sinensis (Tea) consumption has 
been associated with decreased risk of developing cancers like ovary60, oral cavity61, 
stomach62,   colon63 and prostrate64. This is due to catechins (flavonoids) in tea65 
which is a strong antioxidant and angiogenic and ability to inhibit the cell 
proliferation and change carcinogen metabolism66, 67.  
The fruit Citrus limon (Nimbu) contains flavonoid, limonene, flavone, 
nobiletin and tangeretin. The nobiletin, flavonoid and tangeretin are potent inhibitors 
of  tumor  cell  growth  and  turn  on  the  detoxification  of  P450 enzyme system.  They  
inhibited the tumor formation by stimulating the GST enzyme and limonenes 
possessed anticancer activity 68. 
Bark of prunus spp69, leaves of Martynia annusa70 and  stem  of  Rhaphido 
phorapertusa have been studied for anticancer activity. These plants have been used 
against lung, neck and abdominal cancers respectively. 
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REVIEW ON Polycarpaea corymbosa Lamk. 
The free radical scavenging activity of leaves of Polycarpaea corymbosa 
(Family: Caryophyllaceae) was studied. The aqueous extract of Polycarpaea 
corymbosa has showed highest antioxidant activity71.   
The antioxidant and antiradical activity of hydro-alcoholic extract of 
Polycarpaea corymbosa was investigated by different in-vitro methods. IC50 values 
of Polycarpaea corymbosa were found to be 15.10±0.10, 207.96±32.77, 
134.47±21.39, 18.03±3.22, 46.73±3.39 μg/ml in DPPH radical scavenging, nitric 
oxide scavenging, β-carotene linoleate model system, hydroxyl radical scavenging 
and anti-lipid peroxidation activity respectively44.  
The various extracts like petroleum ether, chloroform, acetone and methanol 
of Polycarpaea corymbosa whole plant was possessed antimicrobial activity against 
fifteen bacteria and six fungus. The pathogens like Streptocococus faecalis, 
Enterococcus faccalis, B.thuringiensis, Bacillus subtilis, Staphylococcus aureus, 
Klebsiella pneumonia, Proteus vulgaris, Serratia marcescence, S. paratyphi B 
Salmonella paratyphi, Pseudomonas aeuroginosa and Escherichia coli and fungus 
cultures of Mucur spp,  Paecilomyceslilacinus, Verticillum lecanii, Azospirillum 
lipofererum, Candida albicans and Penicillium spp. The methanol and acetone 
extracts showed good antibacterial and antifungal activity72. 
The anti-inflammatory activity of whole plant of ethanolic extract of 
Polycarpaea corymbosa was screened in rats using a carrageenan induced paw 
edema. The potent anti-inflammatory activity delivered by ethanolic extract at 
500mg/kg73. 
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The phytoconstitutent of ethanolic extract of Polycarpaea corymbosa was 
premeditated using GC-MS. A total of 15 compounds were secluded in GC-MS 
method. Furazano [3, 4-b] pyrazine-5(4H)-one, 6-(1-pyrrolidinyl)-, 1, (2-
Acetoxyethyl)-3, 6-diazahomoadamantam-9-one oxime, cycloarbital, etc was 
identitifed74. 
The antioxidant potential of Polycarpaea corymbosa was  evaluated.  The  
various extracts possessed good 1,1-diphenyl-2-picrylhydrazyl (DPPH), Hydroxyl, 
superoxide and ABTS radical scavenging activity with IC5028.04, 26.93, 31.85 and 
29.83μg/ml75. 
The methanolic aerial extract of Polycarpaea corymbosa (200 mg/kg b.wt) 
was investigated for its anti-nociceptive activity and it has shown good analgesic 
activity  than  root.  The  results  indicated  that  the  analgesic  effect  of  Polycarpaea 
corymbosa methanolic extract was both peripherally and centrally significant76. 
The quantitative analysis of secondary metabolites studied in HPLC from 
Polycarpaea corymbosa was. A total of 5 types of flavonoids and 3 types of steroids 
were found in the methanolic extract of whole plant of Polycarpaea corymbosa77. 
Ethanol extract of Polycarpaea corymbosa possessed hepatoprotective 
activity in albino rats which were given carbon tetra chloride to induce 
hepatotoxicity. Significant increase in superoxide dismutase, serum total protein, 
catalase, reduced glutathione peroxidase and glutathione was observed in extract 
treated groups when compared to control animal group78. 
The acute toxicity and antiulcer profile of pet ether extract of Polycarpaea 
corymbosa was investigated. It was found to be safe upto the dose level 2000mg/kg 
body weight and also produce dose dependent inhibition in indomethacin, ethanol, 
pyloric ligation and cold restraint stress induced gastric lesions in albino rats79. 
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The anti-diarrheal activity of ethanolic extract of Polycarpaea corymbosa 
was evaluated in rats using castor oil induced method. It showed that the plant 
exhibited significant and dose dependent anti-diarrheal activity80. 
Fertility enhancement activity of ethanolic extract of Polycarpaea 
corymbosa in male albino rats was evaluated. It was enhanced sperm concentration, 
motility and serum testosterone level81. 
Moreover, the whole parts of Polycarpaea corymbosa were  used  for  the  
management of inflammatory swellings, ulcer and jaundice in Indian traditional 
medicinal system82. 
From the review of literature it is found that the whole plant of Polycarpaea 
corymbosa have not so far been subjected to scientific studies for anticancer 
potential.  Hence  this  plant  will  be  subjected  to  a  series  of  tests  to  evaluate  the  
anticancer activity. 
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Figure 1:  Polycarpaea corymbosa Lamk. Whole Plant 
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3.1  PLANT PROFILE 
Polycarpaea corymbosa Lamk.  
Botanical source :  Polycarpaea corymbosa Lamk83. 
Family Name   :  Caryophyllaceae 
Synonyms  :  Achyranthus corymbosa  
      Polycarpaea nebulosa  
Common Name  :  Old man’s cap 
Vernacular Names    
Eng     : Old man’s cap 
Sanskrit   : Bhisatta, Okharadi, Parpata  
Hindi    : Bugyale  
Malayalam   : Katu – mailosina 
Tamil    : Nilaisedachi83 , Nilachadachi, Pallippuntu 
Telugu   : Rajuma , Bommasari  
Chinese   : Bai Gu Ding  
Taxonomic classification 84 
Kingdom  :  Plantae 
Phylum  : Tracheophyta 
Class    : Magnoliopsida 
Order    : Caryophyllales 
Family   : Caryophyllaceae 
Genus    : Polycarpaea 
Species  : Polycarpaea corymbosa. 
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Caryophyllaceae is a one of the major dicot family of angiosperms and is 
globally represented by 85 genera and 2,680 species. This family is popularly known 
as the pink family (or) carnation family. 
Description85  
It is an annual or perennial herb leaves are opposite or appear in whorls, 
linear upto 3.5cm long with a brittle at the tip. Flowers are borne in compact heads 
at the end of stems. Sepals are silvery white, turning rich brown with age. Petals are 
small, pink to orange. Fruit is a minute ellipsoid capsule. 
Flowering :  August – September 
Part Used :  Whole Plant 
Habitat 
Sandhills, grassy areas, sometimes as a weed of cultivated ground. 
Distribution83  
It is distributed in India, Burma, Ceylon, Western Peninsula and ascending 
the western Himalayas to 7000 feet. 
Chemical Constituents86 
Alkaloids, Glycosides, Coumarine, Saponins, Flavonoids, Phenols, Steroids, 
Xanthoproteins and Tannins. Polycarpaea corymbosa from which sigmasterol, α – 1 
- barrigenol and camelliagenin have been separated. 
  
Chapter 3      Review of Literature 
 
22 
 
Ethanomedical Uses 85 
v Used both internally and externally as remedy for venomous bites 
from reptiles and animals.  Pounded leaves:  used as poultice over 
boils and inflammatory swellings, used for animal bites and given 
along with molasses in form of a pill in jaundice.  Roots used for 
boils and liver complaints. 
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CHAPTER 5 
MATERIALS AND METHODS 
5.1 COLLECTION AND IDENTIFICATION OF PLANT  
The whole plant of Polycarpaea corymbosa Lamk was collected in the 
month of August and September from Palayamkottai, Tirunelveli District, Tamil 
Nadu, India. The taxonomic identification of the material was authenticated by 
Dr.G.V.S. Murthy, Ph.D., Scientist F & Head, Botanical Survey of India, Southern 
Regional centre, Coimbatore, India. The voucher specimen is deposited in the 
department for future reference (Voucher no: BSI / SRC / 5/ 23 / 2013 – 14 / Tech / 
551). The plant material was dried under shade, segregated, pulverized by a 
mechanical grinder and passed through a 40mesh sieve. The powdered plant 
material was stored in airtight containers and used for further research. 
5.2 PREPARATION OF VARIOUS EXTRACTS OF THE WHOLE 
PLANT OF Polycarpaea corymbosa. Lamk 
About 2 kg of air-dried powdered material from the whole plant was 
successively extracted by hot continuous percolation method in Soxhlet apparatus87 
by increasing polarity of the solvents like petroleum ether, ethyl acetate and ethanol 
for Polycarpaea corymbosa Lamk. The extracts were collected and filtered through 
Whatmann filter paper No. 40 and the solvents recovered from the extracts under 
reduced pressure using rotary evaporator. The concentrated filtrate was then 
evaporated to dryness in vacuum at 350C to 400C. Then the extracts were stored in 
screw capped vials at 40C until further use. The extract obtained with each solvent 
was weighed and the percentage was calculated in terms of dried weight of the plant 
material  and  also  the  colour  and  consistency  of  the  extracts  were  noted.  Solvents  
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used for this entire work were of analytical reagent grade (Merck, Mumbai).  The 
percentage yield was calculated for the extracts with reference to the crude material 
and the extractive values were calculated.  
5.3 PRELIMINARY PHYTOCHEMICAL EVALUATION OF THE 
CRUDE EXTRACTS 
Qualitative  analysis  refers  to  establishing  and  providing  the  identity  of  a  
substance. The phytoconstituents responsible for the therapeutic properties of the 
plant and therefore the pharmacological actions of crude drug is determined by the 
nature of their constituents. Hence the prepared extracts were subjected to 
preliminary phytochemical screening for the revealing of various plant constituents 
present in them.  
 The various extracts of WPC were subjected to the following chemical tests 
separately for the identification of various active constituents88. 
 
S.No Phytoconstituents Description Observation Expected 
1 Alkaloids 89  Dragendroff’ s test: Extract 
treated with Dragendroff’s 
reagent 
Reddish orange 
precipitate 
2 Carbohydrates90 Benedict’s test: Boiling and 
cooling of extract and 
Benedict’s reagent 
Red Precipitate 
3 Proteins and Amino 
Acids91,92  
Ninhydrin Test: Heating 
extract and ninhydrin 
solution 
Blue colour 
4 Phytosterols93  
Libermann Burchard Test: 
Adding acetic anhydride and 
conc. H2SO4 to the extract 
in chloroform 
Solution turning 
red and then blue 
Salkowski Test: Adding 
Conc. H2SO4 to the extract 
in chloroform 
Cherry red colour 
in chloroform layer 
and green 
fluorescence in 
acid layer 
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S.No Phytoconstituents Description Observation Expected 
5 Glycosides88 
Legal Test: Adding Sodium 
niroprusside to the extract in 
pyridine 
Pink or red colour 
Borntrager’s Test: Extract 
and dil. HCl –boiled ,cooled 
and filtered and filtrate 
extracted with chloroform 
Red color 
Keller Killiani Test: Adding 
conc.H2SO4 to the extract in 
acetic acid containing of 
ferric chloride 
Reddish brown 
color turning blue 
6 Saponins88 Extract shaken with water Foam or lather 
formed 
7 Flavonoids 
Shinoda Test: Adding 
magnesium turnings and 
concentrated hydrochloric 
acid to the extract 
Red colour 
8 Tannins and Phenolic 
compounds94 
Adding ferric chloride to the 
extract 
Dark blue or 
greenish black 
colour 
9 Triterpenoids Adding tin and thionyl 
chloride solution to the 
extract 
Pink colour 
10 Fixed Oils 
Saponification Test: Adding 
alcoholic potassium 
hydroxide and 
phenolphthalein and heating 
Partial 
Neutralization or 
Soap formation 
Spot Test: Extract pressed  
between two filter papers 
Oil Stains 
5.4  IN VITRO  ANTIOXIDANT ACTIVITY 
 The various extracts petroleum ether, ethyl acetate and ethanol extract of 
WPC were subjected to in vitro antioxidant activity by DPPH method, superoxide 
radical scavenging activity, nitric oxide radical scavenging activity, hydroxyl radical 
scavenging activity and estimation of total phenol and flavonoids. 
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5.4.1 DPPH photometric assay95  
Principle 
 The  free  radical  scavenging  activities  of  the  extracts  were  evaluated  by  
assessing their ability to reduce the colour of DPPH in ethanol according to Mensor 
et al., 2001.  When reacted  with   antioxidants   DPPH accepts  either  an  electron  or  
hydrogen and loses colour which can be assessed by loss of absorbance at 518nm.  
 DPPH. + AH  à DPPH – H + A. 
Instrument 
          Shimadzu UV Visible Spectrophotometer, Model 1800. 
Reagents 
     0.4mM Diphenyl Picryl hydrazyl radical in methanol. 
Procedure  
 A methanolic solution of 0.5ml of DPPH (0.4mM) was added to 1ml of the 
different concentrations of the plant extract and allowed to react at room temperature 
for 30min. Rutin was used as the reference standard. Methanol served as the blank 
and DPPH in methanol without the extracts served as the positive control. After 
30min, the absorbance was measured at 518nm.  
 The percentage scavenging was calculated using the formula                 
[(AbsControl-AbsTest) / AbsControl] x 100. A graph was constructed by plotting 
concentration versus percentage inhibition and the linear regression equation 
calculated. The Inhibitory concentration for reduction of 50% absorbance (IC50) was 
calculated using linear regression analysis. A triplicate reading was taken and 
average was calculated.   
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5.4.2 Superoxide radical scavenging activity96 
Principle  
 Superoxide radical (O2-) generated from the photo reduction of riboflavin 
and it was deducted by nitro blue tetrazolium dye (NBT) reduction method. The 
measurement of superoxide anion scavenging activity was performed based on the 
method described by Winterbourne et al., 1975. 
Instrument 
 Shimadzu UV Visible Spectrophotometer, Model 1800. 
Reagents 
 1.5mM nitro blue tetrazolium (NBT). 
 0.1M EDTA. 
 0.12mM riboflavin. 
 0.067M phosphate buffer. 
Procedure 
 The sample was mixed with the above reagents and the control tubes were 
also set up wherein DMSO was added instead of sample. The reaction mixture was 
illuminated for 30min and the absorbance at 560nm was measured against the 
control samples. Quercetin was used as the reference compound.  
 The percentage scavenging was calculated using the formula                     
[(AbsControl-AbsTest)/AbsControl]  x  100.  A  graph  was  constructed  by  plotting  
concentration versus percentage inhibition and the linear regression equation 
calculated. The concentration of the sample required for 50% reduction in absorbance 
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(IC50) was calculated using linear regression analysis. A triplicate reading was taken 
and average was calculated.   
5.4.3  Nitric oxide radical scavenging activity97 
Principle 
 Nitric oxides is spontaneously generated from sodium nitroprusside in 
aqueous solution at physiological pH, which then interact with oxygen to turn out 
nitrite ions. It can then be estimated by the use of Griess Illosvery reaction at 540nm 
by the method of Garrat (1964).  
Instrument 
 Shimadzu UV Visible Spectrophotometer, Model 1800. 
Reagents 
 10mM sodium nitroprusside 
 1M phosphate buffered saline 
 Sulphanilic acid reagent (0.33%) 
 Napthylethylene diamine dihydrochloride (1% NEDA) 
Procedure 
 The reaction mixture (3ml) containing the above ingredients was incubated 
with plant extract at 250C for 150min. After incubation, 0.5ml of the reaction 
mixture containing nitrite was pipetted out and mixed with 1ml of sulphanilic acid 
reagent (0.33%) and allowed to stand for 5min for completing diazotization. Then 
1ml of naphthylethylene diamine dihydrochloride was added, mixed and allowed to 
stand for 30min.  
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 The percentage scavenging was calculated using the formula                  
[(AbsControl-AbsTest)/AbsControl] x 100. A graph was constructed by plotting 
concentration versus percentage inhibition and the linear regression equation 
calculated. The concentration of the sample required for 50% reduction in 
absorbance (IC50) was calculated using linear regression analysis. A triplicate 
reading was taken and average was calculated.   
5.4.4 Hydroxyl radical scavenging activity98  
Principle 
 The assay is based on quantification of degradation product of 2-deoxy ribose 
by condensation with TBA. Hydroxyl radical was generated by the Fe3+ -Ascorbate –
EDTA –H2O2 system (Fenton reaction). The method described by Elizabeth and Rao 
(1990) was adopted. 
Instrument 
 Shimadzu UV Visible Spectrophotometer, Model 1800. 
Reagents 
         2.8mM deoxyribose 
       0.1mM EDTA 
  1mM hydrogen peroxide 
  20mM KH2PO4-KOH 
  0.1mM ascorbic acid 
Procedure 
 The above reaction mixture was mixed with various concentrations of plant 
extract in a final volume of 1ml. Rutin was used as standard. The reaction mixture 
was incubated for 1h at 370C. Deoxyribose degradation was measured as TBARs. 
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The percentage scavenging was calculated using the formula  
[(AbsControl-AbsTest) / AbsControl] x 100. A graph was constructed by plotting 
concentration versus percentage inhibition and the linear regression equation 
calculated. The concentration of the sample required for 50% reduction in 
absorbance (IC50) was calculated using linear regression analysis. A triplicate 
reading was taken and average was calculated.   
5.4.5 Estimation of Total Phenol and Flavonoid content  
Total phenol99 
Principle 
 The total phenolic content was estimated by Folin’s phenol reagent (FPR) 
method based on Mallick and Singh (1980). Folin’s phenol reagent is reduced to a 
mixture of oxides of molybdenum and tungsten when treated with Phenolic 
compounds. The blue colour obtained showed an absorption maximum at 650nm 
which is proportional to the quantity of oxidized phenolic compounds. 
Instrument 
 Shimadzu UV Visible Spectrophotometer, Model 1800. 
Reagents 
 80% ethanol 
 0.5ml Folin Phenol reagent 
 Sodium carbonate (20%) 
Procedure 
 To 3ml of extract, Folin’s phenol reagent and sodium carbonate were added 
and kept in boiling water bath for 1min and the absorbance was measured at 650nm 
in a Spectrophotometer. A standard was run by using Gallic acid.  
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 A calibration curve was generated by plotting concentration of gallic acid 
versus absorbance. The concentration was determined by using regression analysis 
and  expressed  in  terms  of  mg  of  gallic  acid  equivalent  per  gm  of  extract  (mg  
GAE/g).  
Total Flavonoids 100 
Instrument 
 Shimadzu UV Visible Spectrophotometer, Model 1800. 
Reagents 
v 1% Vanillin in 70% conc. H2SO4. 
Procedure: 
 0.5ml of extract was added with 4ml of the vanillin reagent and kept in a 
boiling water bath for 15min. The absorbance was read at 360nm. A standard was 
run by using catechol (110µg/ml). The amount of flavonoids present was determined 
by Linear regression analysis. The total Flavonoid content was expressed as mg 
catechol equivalents /g of extract.  
5.5  In vitro CYTOTOXICITY 
In vitro Cytotoxicity of various extracts of WPC  
 Cancer continues to represent the largest cause of mortality in the world and 
claims over 6 million lives every year101. Drug development programme involve in 
the preclinical screening of a vast number of chemicals for their specific and 
nonspecific cytotoxicity against many types of cells. Use of in vitro assay system for 
the screening of potential anticancer drug has been a common practice almost since 
the origin of cancer therapy in 1946. The National Cancer Institute now regularly 
evaluate the growth inhibitory properties of every compound under test against a 
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panel of human cancer cell lines which are agents of major human tumor types. 
There are numeral advantages in in vitro test using cell cultures which include 
analysis  of  species  specificity,  feasibility  of  using  only  a  small  amount  of  test  
substance and facility to do mechanistic studies. A novel antineoplastic drug should 
possess cytotoxicity at low concentration against cancerous cell lines and should be 
safe  against  normal  cell  lines  even  at  higher  concentration102.The direct anticancer 
activity of the plant extracts can be tested under in vitro conditions using cultured or 
fresh preparation of various tumour cell types. Once the activity has been detected, 
the study has to be followed up vigorously to find therapeutic efficacy and safety. 
5.5.1 Cell lines 
 Human breast cancer (MCF-7) and human leukemia (HL-60) cell lines were 
provided by Deshpandey Laboratory, Bhopal, India. HepG2 (human cancerous liver 
cell  lines),  HT29 (human colon cancer cell  lines),  PC3 (human prostate cancer cell  
lines) were obtained from National Centre for Cell Sciences, Pune, India.  
5.5.2 Preparation of test material 
Stock solution 
 DMSO was used for 95% reconstitution of various extracts and stock 
solutions of 20mg/ml of various extracts were prepared one day in advance. Multiple 
aliquots of each sample were stored for initial tests and retests, if necessary. Stock 
solution was filtered and sterilized.  
Working test solution 
      On the day of assay, an aliquot of frozen stock solution was thawed at room 
temperature and 100μg/ml concentration of the extract was prepared by serial 
dilution of stock solution using the complete growth medium containing 50mg/ml of 
gentamycin. 
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Positive control 
 The positive control used was Doxorubicin. 
In vitro Assay for cytotoxic activity 
 The cytotoxic potential of various extracts of WPC was determined by using 
human cancer cell lines. The cell lines were allowed to grown in tissue culture plates 
in the presence of test material. The cell growth was deliberate on ELISA reader 
after staining with 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium 
bromide (MTT)-reagents. The yellow dye MTT was converted into a blue formazan 
product.  
Preparation of cell suspension for assay  
 The desired human cancer cell line was grown in multiple TCFs at 37°C in 
an atmosphere of 5% in CO2 and  90%  relative  humidity  in  a  complete  growth  
medium with enough number of cells as per the requirement depending upon 
numbers of test samples. The flasks with cells at sub-confluent stage were selected 
for the assay. Cells were harvested by the treatment with Trypsin- EDTA and added 
to complete growth medium and bring to an end the action of trypsin was brought to 
an end. Cells were detached to single cell suspension by gentle pipetting action and 
the viable cells were counted in haemocytometer using trypan blue dye. The cell 
viability  at  this  stage  was  >97%.  The  viable  cell  thickness  was  adjusted  to  
5,000-40,000 cells/100μl depending upon the cell line103. 100μl of cell suspension 
mixed with 100μl of complete growth medium was transferred into each well and 
then the plates were incubated at 37°C for 24h in an atmosphere of 5% CO2 and 
90% relative humidity in a Carbondioxide incubator. After 24h the test sample, 
DMSO (vehicle control) and positive control was added.  
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Addition of test materials   
 Working  solutions  of  the  test  materials  100μl  and  positives  control  was  
added to equal quantity of growth medium into the wells in the tissue culture plate. 
It was prepared 24 hours in advance containing either cells or complete growth 
medium in a final volume of 100μl. The plates were incubated at 37°C for 48hours 
in an atmosphere of 5% Carbon dioxide and 90% relative humidity. The cell growth 
was determined after 48hours by MTT assay.  
MTT assay104, 105  
 The MTT assay was performed according to a slight modification of the 
procedure reported by Mosman (1983) 104. Cells were cultured in minimum essential 
medium (MEM) supplemented with glutamine (0.6g/L), gentamicin (25mg/ml) and 
10% fetal calf serum at 37°C and in humidified 5% CO2. For experiments, cells 
were plated in 96-well plate (105 cells/ well for adherent cells or 0.3X106 cells/ well 
for suspended cells in 100µL of medium). After 24hrs, the extracts (100µg/ml) 
dissolved in DMSO (1%) was added to each well and incubated for 96hrs. The 
control groups received the same amount of DMSO. Doxorubicin (100µg/ml) was 
used as positive control. Growth of tumoral cells was quantified by ability of living 
cells to reduce the yellow dye MTT to a blue formazan product. At the end of 96hrs 
incubation, the medium in each well was replaced by fresh medium containing 
0.5mg/ml of MTT. Four hours later, the formazan product of MTT reduction was 
dissolved in DMSO and absorbance was measured at 550nm. Drug effect was 
quantified as the percentage of control absorbance of reduced dye at 550nm. The 
experiments were performed in triplicate. Percentage  inhibition was calculated and 
plotted against the concentration which was used to calculate IC50 values. 
Percentage growth inhibition in presence of test material was calculated as follows: 
 =100 – (Absorbance of test wells ⁄ Absorbance of control wells) x 100. 
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Determination of Activity  
More than 70% growth inhibition at the concentration of 100μg/ml is 
considered to be active.  
5.6. ACUTE ORAL TOXICITY STUDY (AOT) 
5.6.1 AOT studies of various extracts of WPC 
 For assessing the safety and toxicity of the drug was studied by using 
animals under varying conditions of drug administration. The preclinical 
toxicological studies are the major key for fixation of initial dose in humans and 
supports for clinical trial. 
 The AOT studies of various extracts of WPC were carried as per the 
Organization of Economic Co-operation and Development (OECD guideline 
number 423) Guidelines106. Depending on the mortality and/or the morbidity status 
of the animals, an average 2-4 step may be necessary to allow judgment on the acute 
toxicity of the substance/extracts. This procedure is reproducible, uses very few 
animals. The acute toxic class method is based on biometric evaluation with fixed 
doses, adequately separated to enable a substance to be ranked for classification 
purpose and hazard assessment. 
 The OECD-423 method used for pre-defined doses and the results permit a 
substance to be ranked and classified according to the GHS for classification of 
chemicals, which produces acute toxicity. 
5.6.2 Acclimatization of Animals 
 Swiss Albino mice (25-30g) were maintained under standard laboratory 
condition at the centre for experimental animals in Madras Medical College. The 
Institutional Animal Ethical Committee’s clearance was obtained vide reference 
1/243/CPCSEA dated 22/11/2013 for the study of the extracts of the WPC. After ten 
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days of acclimatization, the animals were randomly assigned for the acute toxicity 
groups. Each group containing 3 animals were housed in labeled cages with solid 
plastic sides and floor with stainless steel grid tops. The animals were permitted free 
access to standard pellet diet and water ad libitum. They were maintained under 
controlled laboratory conditions of 12h dark/light cycle, 22 ± 2ºC temp and 45-60% 
humidity. 
5.6.3 Administration of various extracts from WPC 
The AOT of various extracts of WPC was carried out as per OECD-423 
guidelines for deciding the safe dose of administration to animals.  Three animals 
were used for each step of study. The animals were fasted prior to dosing (food was 
withdrawn overnight and water was withdrawn 3h before drug administration) 
following the period of fasting.  
 The animals were weighed and the extracts were given in a single dose, as 
1% suspension in gum acacia, by oral intubation. Food was withheld for further one 
hour after the administration of drug. The starting dose levels selected for the study 
was 5mg/kg and the dose was increased step by step to 5, 50, 300 and 2000mg/kg 
body weight. The mortality of the animals dosed at one step will determine the next 
step. The procedure flow chart described the procedure followed for each of the 
starting doses (Fig: 2).  
 The time interval between treatment groups was determined by the onset, 
duration and severity of toxic signs. Treatment of animals at the next dose should be 
delayed until one is confident of survival of the previously dosed animals.  
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Acute toxicity of various extracts from WPC 
Group I Control (1% suspension gum acacia) 
Group II    Petroleum ether Extract 
Group III    Ethyl acetate extract 
Group IV    Ethanol extract 
5.6.4 Observations 
The animals were observed individually for every 30min after dosing for the 
first 24h and thereafter daily for a total of 14 days. The time at which signs of 
toxicity appear and disappear was observed systematically and recorded for each 
animal. Additional signs of toxicity such as changes in body weight, eyes and mucus 
membranes, skin and fur, circulatory system, respiratory system, central nervous 
system, autonomous system, somatomotor activity and behaviour pattern were also 
recorded. Attention was given to observe the tremors, salivation, convulsions, 
diarrhoea, lethargy, sleep and coma. The presence or absence of compound-related 
mortality  of  the  animals  dosed  at  one  step  will  determine  the  next  step.  Any  
mortality during the experiment for 14 days were observed and recorded. 
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 Fig 2:     Flow chart for acute toxic method (OECD guidelines 423) 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
· 0, 1, 2 ,3: number of moribund or dead animals of each step 
· GHS: Globally harmonized classified system (mg/kg b.w.) 
· X- Un classified 
5.7 ANTICANCER ACTIVITY 
            In vivo anticancer models in animals employing transplantable tumors as 
well as EAC induced carcinoma may be used to evaluate the anticancer potential. 
While various medicinal plants are used for the management of cancer in Indian 
traditional systems of medicine, most of these plants are not scientifically evaluated. 
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If a customary and determined ethno pharmacological study is carried out, one or 
more plants used in diverse ethnomedical practices are sure to provide valuable 
anticancer drugs101.  
 Anticancer activity was investigated on various extracts from WPC in mice 
fed with commercial pellet diet.  
 Different extracts such as petroleum ether, ethyl acetate and ethanol extracts 
obtained from WPC and standard 5-flurouracil were given orally to mice, which 
were also fed with commercial pellet diet. The anticancer activity of the extract was 
compared with standard, control and cancer induced animals. The extracts were 
suspended in 1% gum acacia. 
5.7.1 EXPERIMENTAL DESIGN 
Male Swiss albino mice (25 to 30gram) were procured and maintained in 
Central Animal House in the Madras Medical College, Chennai. The Institutional 
Animal Ethical Committee’s clearance were obtained vide reference 1/243/CPCSEA 
dated 22/11/2013 for the study of the extracts of WPC.  
 The animals were housed in polypropylene cages and placed at room 
temperature (27 ± 2°C) with relative humidity of 55 ± 5%, in an experimental room 
under  a  12h  light/12h  dark  cycle.  They  were  fed  on  a  commercial  pellet  diet  and  
water was provided during the period of study. EAC cells were obtained through the 
courtesy of Amala cancer Research center, Kerala (Thrissur), India. The EAC cells 
were maintained in vivo in Swiss albino mice, by intraperitoneal (i.p) transplantation 
of 1×106 cells/ mouse after every 10 days107. 
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Treatment schedule107 
 Male Swiss albino mice were divided into 6 groups (n=12) and treated as 
given below. 
GROUPS DESCRIPTION 
Group I Normal mice 
Group II Inoculated with 1×10 6 EAC cells/mouse 
Group III Inoculated with 1×10 6 EAC cells/mouse and treated with           
pet ether extract (200 mg/kg b.wt) 
Group IV Inoculated with 1×10 6 EAC cells/mouse and treated with 
ethyl acetate extract (200 mg/kg b.wt) 
Group V Inoculated with 1×10 6 EAC cells/mouse and treated with 
ethanolic extract (200 mg/kg b.wt) 
Group VI Inoculated with 1×10 6 EAC cells/mouse and treated with 5-
fluorouracil (20 mg/kg b.wt. i.p) 
 Except group I (normal), all the groups were injected with EAC cells (1×10 6 
EAC  cells/mouse)  intraperitoneally.  This  was  taken  as  day  zero.  On  the  first  day,  
normal saline was administered to group I (normal) and group II (EAC-bearing). The 
various extracts of WPC at the dose of 200 mg/kg b.wt. p.o was administered to 
groups III, IV and V for 14 days. The standard drug 5-fluorouracil (20 mg/kg b.wt. 
i.p) was administered to group VI for 14 days. After the last dose and 18-hr fasting, 
six mice from each group were sacrificed for various haematological and liver 
biochemical parameters. 
 Body weight of the experimental mice was recorded from the day 1 to day 
15 of the study. Average body weight on 15th day was determined. 
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 The mean survival time and percentage increase of life span was calculated 
by using the following formula107: 
Mean Survival Time (MST) in days = (Day of the first death + Day of the last death)  
    ____________________________________ 
                                                                                  2     
 
Percentage increase of life span (ILS) = {(MST Test / MST control) -1} X 100     
Ehrlich ascitic carcinoma tumor growth response 
Tumor Volume107 
The mice were dissected and the ascitic fluid was collected from the 
peritoneal cavity. The volume was measured by taking it in a graduated centrifuge 
tube and PCV determined by centrifuging at 1000g for 5min. 
Tryphan blue exclusion assay for cell viability108 
The dye exclusion test is used to find out the number of viable cells present 
in a cell suspension. It is based on the principle that live cells have intact with cell 
membranes that exclude certain dyes such as tryphan blue, Eosin or propidium 
whereas  dead  cells  do  not.   A  cell  suspension  is  simply  mixed  with  dye  and  then  
visually examined to conclude whether cells take up or exclude dye. If the cells 
contain a clear cytoplasm is viable, if not it is non-viable. 
Reagents 
a) PBS (pH 7.4): 0.8g NaCl, 0.02 g KCl , 0.144 Na2 HPO4, 0.024g KH2PO4. 
Dissolve the above reagents in 100ml of distilled water. 
b) Saline (0.9% NaCl). 
c) 0.4% trypan blue (Dissolve 0.4g of trypan blue in 100ml of saline). 
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Procedure 
Centrifuge an aliquot of cell suspension being tested for viability 5min at 100 x 
g and discard the supernatant.  Resuspend the cell  pellet  in 1ml PBS. Mix 1 part  of 
0.4% trypan  blue  (0.4% in  saline)  and  1  part  of  cell  suspension  (dilution  of  cells).  
Allow the mixture to incubate for 3min at room temperature. Apply a drop of trypan 
blue cell mixture to a haemocytometer. Place the haemocytometer on the stage of a 
microscope and focus on the cells. 
v Count the unstained (viable) and stained (unviable) cells separately in the 
haemocytometer. 
 Cell count (cells/ml) = (No of cells counted x dilution factor)                                           
     (Area x thickness of liquid film). 
5.7.2 BIOCHEMICAL ESTIMATION 
After the examination period the animals were fasted overnight and then 
sacrificed by cervical dislocation method under mild anesthesia. Blood was anti-
coagulated by adding EDTA and used for determining the various haematological 
parameters which includes RBC, Hb, total WBC and differential count (neutrophils, 
lymphocytes and monocytes).  
 The liver tissue was examined for the determination of lysosome specific 
cancer markers (cathepsin-D, β-D glucuronidase and acid phosphatase), liver 
marker enzymes (5’-nuclotidase and lactate dehydrogenase) and membrane bound 
ATPase (Na+/K+ ATPase and Mg2+ ATPase), plasma glucose, liver glycogen, DNA 
and RNA content. 
10% Liver homogenate from different  treatment groups were analyzed for 
in vivo antioxidant studies. The liver tissue was cleared off, weighed accurately and 
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portions of liver tissues were blotted, homogenised with methanol (3 Volumes). 
The lipid extract was obtained by method of Nichans et al109. It was used for the 
estimation of thiobarbituric acid reactive substances (TBARs) .  
Liver  tissue  sample  was  used  for  various  estimation  of  thiobarbituric  acid  
reactive substances and estimation of enzymatic antioxidant like Glutathione 
peroxidase (GPx), Superoxide dismutase (SOD) and Catalase (CAT). Another 
portion of tissues was homogenized with phosphate buffer saline and used for the 
estimation  of  non  enzymatic  antioxidants  like  Glutathione  (GSH),  Vitamin  E  and  
Vitamin C. 
TOTAL RED BLOOD CELL COUNT BY HAEMOCYTOMETRY108 
Principle 
 The blood spectrum is diluted (usually 200 times) with red blood cell 
diluting fluid which does not remove the white blood cells but allow the red cells not 
to be counted under 40 X magnification in a known volume of fluid. Finally, the 
number of cells in undiluted blood is calculated and reported as the number of red 
cells/cu mm. 
Reagents          
a)  Red blood cell diluting fluid  
Trisodium citrate- 3.13g 
37% formaldehyde – 1.0ml  
Distilled H2O – 100ml 
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Procedure 
 4ml of the diluting fluid was taken in a test tube. Added 20µl of EDTA anti-
coagulated blood and mixed well which resulted in 201 times dilution of blood 
sample. Red blood cells in the diluted sample were counted in a haemocytometer. A 
small quantity of diluted blood was placed on the counting chamber. The counting 
chamber  was  kept  on  the  bench  for  3  minutes  to  allow  the  cells  to  settle.  The  
counting chamber was placed on the stage of the microscope between the clips to the 
hold slide so that the counting chamber cannot be moved. Using low power (10X) 
objective, the light and focus on the wall of the counting chamber was adjusted. 
Then slowly the stage was moved towards the middle of the slide until the rulings 
are visible and the focus was sharpened. 
 The large square in the centre was located with 25 small squares. It was 
placed  in  the  middle  of  the  field  of  vision  and  the  distribution  of  red  cells  on  the  
entire area was examined. Then the high-dry objective (40X) was selected and the 
chamber was moved so that the smaller upper left corner was completely in the field 
of vision. The number of red cells seen on the small square of the upper left corner 
was counted which is divided into 16 smaller squares to facilitate counting. The 
counting was repeated with four other squares. The counts of all the corner squares 
were completed and then moved to the center square, which is the fifth square. The 
total of all the cells counted in 5 squares was recorded. 
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DETERMINATION OF HAEMOGLOBIN108 
Cyanomethhaemoglobin method 
Principle 
 Cyanomethhaemoglobin method is a colorimetric procedure for 
determination of haemoglobin concentration. An aliquot of well mixed whole blood 
is taken and reacted with a solution of potassium cyanide and potassium ferricyanide 
(Drabkins solution). The chemical reaction yields a product of stable color-the 
cyanomethaemoglobin. The intensity of the color is proportional to the haemoglobin 
concentration. 
TOTAL LEUKOCYTE COUNT BY HAEMOCYTOMETRY108 
Principle 
 Blood is diluted with acid solution which removes the red cells by 
haemolysis  and  also  accentuates  the  nuclei  of  white  cells;  thus  the  counting  of  the  
white blood cells becomes easy. Counting is done with a microscope under low 
power (10X) and knowing the volume of fluid examined and the dilution of the 
blood, the number of white cells per cu mm (or µl) in undiluted whole blood is 
calculated. 
Reagents  
WBC diluting fluid  
v Glacial acetic acid - 2ml  
v Distilled water – 100ml 
v Aqueous methylene blue solution (0.3% w/v) -10 drops 
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Procedure 
 Into a test tube, 0.38ml of WBC diluting fluid was pipette out. 20µl of EDTA 
anti-coagulated blood was pipetted out with the help of sahli pipette and well-mixed. 
The blood was gently mixed well by swirling and waited for 2 minutes for complete 
haemolysis. Dilution of the blood was (0.38+0.02)/0.02=20. The counting chamber 
was filled with 1µl of diluted sample. The counting chamber was placed on the stage 
of the microscope and the objective was turned to low power and the grid was 
located. The cells in four corner squares of the haemocytometer were counted. 
DIFFERENTIAL COUNTING108 
Principle 
 Differential count is the percent distribution of various white blood cells in 
the peripheral blood as determined from a blood smear stained with the leishman 
stain. The staining is done with a polychromatic stain that includes eosin and 
methylene blue in its preparation (Leishman stain). The polychromatic stain induces 
multiple  colors  when  applied  to  cells.  In  addition  to  the  relative  WBC  count,  
microscopic study of a blood smear helps to get an overall picture of blood. 
Reagents  
Leishman stain:  0.2% in acetone free methanol 
Buffered water 
v Disodium hydrogen phosphate -3.76g 
v Potassium dihyrogen phosphate anhydrous- 2.10 g 
v Distilled water- 1000ml 
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Procedure 
 Differential count involved in the preparation of smear, staining of smear and 
microscopic observation. 
Preparation of smear 
 A drop of well mixed EDTA-blood specimen was transferred to clean grease 
free slide. The drop was placed approximately 1cm away from the end and of about 
5mm diameter. With the help of the spreader a smear was made.  
Staining of smear 
 Leishman stain contains methanol which fixes the smear in the staining 
process.  Fixation prevents distortion of cells and smears can be kept for a long time. 
Before staining, the smear was initially fixed with methanol for 2 to 3minutes. The 
smear was covered with diluted Leishman stain for 7-10minutes. The stain was 
washed off with buffered water. Finally fresh buffered water was added for 2-3 
minutes to differentiate the film. The time taken for differentiate depend on the stain 
and pH of the water used. All water adhering to the slide was shaken off and set in 
an upright position in a drying rack. The smear was examined under the microscope. 
The  various  types  of  white  cells  were  identified  on  the  basis  of  the  following  
characters as a result of staining with leishman stain. 
Ø Granulocytes  
 These are cells with granulated cytoplasm which stains faint pink. These 
include neutrophils, eosinophils and basophils. 
  
Chapter 5      Materials and Methods 
51 
 
Ø Neutrophils  
 Pale pink cytoplasm with fine mauve-coloured granules, include band and 
segmented forms (lobes); normally 3 to 4 lobed. 
Ø Eosinophils 
 Cytoplasm stains faint pink and contains large red and red orange granules. 
Ø Basophils  
 Cytoplasmic granules large, dark, and blue – black which fill the cell and 
obscure the nucleus. 
Ø Lymphocytes 
 Large-sized lymphocytes have clear blue cytoplasm on the margin of the 
nucleus. If the smaller lymphocytes dark violet coloured nucleus almost fills the 
entire cell and has a rim of clear cytoplasm. 
Ø Monocytes  
 Largest  in  size  of  all  white  cells,  wavy  margin  of  cytoplasm,  grey-blue  
cytoplasm; kidney-shaped nucleus. 
LYSOSOME SPECIFIC CANCER MARKERS 
Cathepsin-D110 
Principle 
Acid Denatured haemoglobin    Cathepsin D    TCA- soluble peptides.  
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Reagents  
a) Sodium acetate buffer 0.1M, pH 3.6; 92.5ml of 0.1M acetic acid was mixed 
with 7.5ml of 0.1M sodium acetate solution.  
b) Substrate (1.5%): 1.5g of Hb was dissolved in 100ml sodium acetate buffer. 
c) TCA (5%): 5g of TCA was dissolved in 100ml of distilled H2 O.  
d) Folin’s copper (FC) reagent (1:1 dilution). 
e) Alkaline copper(AC) reagent (50:1 ratio). 
Soln A: 2% Na2 CO3 in 0.1N NaOH  
Soln B: 0.5% Cuso4, 5H2O in 1% sodium potassium tartarate  
f) Standard: A solution of tyrosine in the concentration of 10mg/100ml was 
prepared with 0.1N HCl. 
Procedure 
 0.9ml of buffered substrate was mixed with 0.1ml of enzyme preparation and 
incubated for 2hours at 370C. The reaction was stopped with 1.0ml of 5% TCA and 
the  samples  were  centrifuged  for  10mins.  To  the  control  tubes,  the  enzyme  
preparation was added after the addition of TCA. To 1.0ml of supernatant, 1.0ml of 
5% sodium hydroxide and 4.5ml of AC reagent were added. After 10mins, 0.5ml of 
FP reagent was added and the color developed was read at 640nm after 15mins. The 
standards were treated similarly. Enzyme activity is expressed as µmoles of tyrosine 
liberated /hour/mg/protein at 370C . 
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Determination of β-D-Glucuronidase111 
Principle 
Phenolphthalein Glucuronide + H2O      β-Glucuronidase     Glucuronate  +  
Phenolphthalein. 
Reagents:  
Acetate buffer:  0.1M, pH 4.5 
Solution A: 410.2 mg of sodium acetate was dissolved in 50ml of distilled H2O. 
Solution B: 0.29ml acetic acid was mixed with 50ml distilled H2O. 4.9ml of 
solution A and 5.1ml of solution B were mixed before use. 
Glycine buffer (pH 10.7)  
 This was prepared by mixing equal volume of 0.2M glycine, 0.125M sodium 
carbonate and 0.1M sodium chloride in distilled H2O. 
 Substrate: p- nitrophenyl-β-D-Glucuronidase (1 mg/ml in distilled H2O). 
 Standard: 5mg of p- nitrophenyl in 100ml of distilled H2O. 
Procedure  
 0.5ml of substrate, 0.05ml of acetate buffer, 0.3ml of homogenate was 
incubated at 370C, for 1hour. The reaction was arrested by the addition of 3.9ml of 
glycine buffer. Standards were run simultaneously along with a blank. The color 
developed was read at 420nm using a colorimeter. The enzyme activity is expressed 
as µmoles of p- nitrophenyl liberated /L. 
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Estimation of Acid Phosphatase112 
Principle  
 The  enzyme  catalyses  the  hydrolysis  of  phosphate  esters  to  H3PO4 and 
alcohol. Amount of H3PO4    produced, during hydrolysis is a measure activity. The 
liberated H3PO4 containing inorganic phosphate is estimated by Fiske subbarow 
method. 
Reagents:  
a) Citrate buffer, pH 5  
A= 0.1M solution of citric acid (21.01g in 1000ml) 
B= 0.1M solution of citrate (29.41g in 1000ml) 
20.5ml of Citrate A +  29.5ml  of  Citrate  B  in  diluted  to  a  total  volume  of  
100ml with distilled water. 
    b) Substrate: 0.1M sodium β-glycerophosphate (3.15g in 100ml of citrate buffer)  
    c) 10% TCA: 10g in 100ml of distilled water 
    d) Ammonium molybdate solution: 5gms of ammonium molybdate were 
dissolved in 200ml of 5N H2SO4. 
    e) ANSA (1 – amino – 2 – naphthol – 4 - sulfonic acid) solution: 30g sodium 
metasulphite, 6g sodium sulfite and 500 mg of 1 -amino-2-naphthol-4-sulfonic 
acid  were dissolved separately in small quantities of water. All the solutions 
were combined and made upto 250ml with water. It was allowed to stand 
overnight and filtered. It was then stored refrigerated in an amber-coloured 
bottle. 
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f) Standard phosphate: 35mg of pure KH2PO4 was dissolved in water. 10ml of 
1N H2SO4 was added and made upto 100ml with distilled water. 
g) Working standard: 10ml of the stock was diluted to 100ml with water in a 
standard flask. 
Procedure  
Buffered substrate (2ml) was added to the test and control tubes and placed 
in a water bath at 370C for 5minutes. 0.1ml of sample was added to test tubes and 
incubated at 370C  for  1hour.  The  tubes  were  removed  and  1ml  of  10%  TCA  was  
added to all the tubes. To the control tubes alone 0.1ml of sample was added, shaken 
well and centrifuged. 1ml of supernatant was taken with 1ml of ammonium 
molybdate and 0.4ml of ANSA solution was added one after another. Final volume 
was made upto 10ml with distilled water. Standard ranging from 8-40µg 
concentration was added and treated similarly as above. The intensity was read at 
660nm after 10minutes. 
LIVER MARKER ENZYMES  
Enzymatic assay of 5’-nucleotidase113 
The activity of 5’- nucelotidase is determined as the amount of liberated 
phosphate from 5’-adenosine monophosphate (5’AMP) at pH 9.0 which is measured 
spectrophotometrically at 660nm. 
           5’-AMP + H2O     5’- nucleotidase          adenosine +Pi 
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Reagents:  
a) 200 mM glycine buffer, PH 9.0 at 370 C: (prepare in 10N sulphuric acid) 
b) 66mM adenosine 5’ monophosphate mol.wt: 391.91  
c) 200mM magnesium sulfate mol.wt: 246.48     
d) Reagent A: 10% ammonium molybdate solution (prepare in 10N sulphuric 
acid)  
e) Reagent B: Taussky-shorr reagent (TSCR): prepared by making 10ml of 
reagent A to 100ml with deionized water and added 5g of ferrous sulphate 
heptahydrate. 
f) Phosphorous standard: 35.1mg potassium dihydrogen phosphate was 
dissolved in 1ml of 10N H2SO4 and made up to 100ml with distilled water. 
1ml of the stock contains 18mg of phosphorous. 
g) Working standard: (1in 10 dilution) 10ml of the stock was diluted to 100ml 
with distilled water. 1ml of this solution corresponds to 8mg of phosphorus. 
Procedure  
To the test and control tubes, 1.5ml of glycine buffer, 0.15ml of 5’-AMP and 
0.10ml of MgSO4 were added and the final concentration was made upto 2ml with 
deionized water. The final concentration in this mixture was 150mM glycine, 
5.0mM adenosine 5’-monophosphate and 10mM magnesium sulfate. The mixture 
was equilibrated at 370C for 5minutes. Then 0.1ml of sample was added to the test. 
It was immediately mixed and incubated at 370C for 2mins.  4ml of reagent B was 
added to all the tubes. Sample (0.1ml) was added to control tubes. The final volume 
was made upto 4.1ml by adding 2ml of deionized water. The absorbance was 
measured at 660nm.  
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 1  to  5ml  of  working  standard  solutions  corresponds  to  8  to  4µg  of  
phosphorous was taken and the final volume was made up to 5ml. Then 4ml of 
reagent B was added to the standards. Blank was read similarly as above. One unit is 
defined as 1.0µmole of inorganic phosphorus hydrolysed from adenosine                       
5’-monophosphate per min at pH 9.0 at 370C. 
Estimation of lactate Dehydrogenase114 
Principle    
The lactate is acted upon by lactate dehydrogenase  from pyruvate in the 
presence of NAD. The pyruvate forms Pyruvate phenyl hydrazone with 2, 4-
dinitrophenylhydrazine. The color developed was read in a spectrophotometer at 
440nm. 
Reagents  
a) Glycine buffer: 7.505g of glycine and 5.85g of sodium chloride were 
dissolved in 1litre of water.  
b) Buffered substarate: 125ml of glycine buffer and 75ml of 0.1N NaOH were 
added to 4g of lithium lactate and mixed well. 
c) Nicotinamide adenine dinucleotide: 10mg of NAD+ was dissolved in 2ml of 
water.  
d) 2,4-dinitrophenyl hydrazine : 20mg of DNPH was dissolved in 100ml of 1N 
HCl  
e) 0.4N NaOH  
f) Standard : 11mg of sodium pyruvate was dissolved in 100ml of buffer                
(1µ mole of pyruvate/ml) 
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Procedure  
0.5ml of buffer substrate and 50µl of sample were taken in each of two tubes. 
0.1ml of water was added to the blank. Then to the test, 0.1ml of NAD was added. It 
was mixed and incubated at 370C for 15minutes. Exactly after 15minutes, 0.5ml of 
dinitrophenylhydrazine was added to test and control tubes. It was left for further 
15minutes. Then 5ml of 0.4N NaOH was added and the color developed was read 
immediately at 440nm. A standard curve with sodium pyruvate solution with the 
concentration range 0.1-1.0µ mole was obtained. The enzyme activity is expressed 
as units/mg protein in tissues. 
Estimation of Na+ K+ ATPase115 
Principle 
Na+ K+ ATPase  transports  Na,  K  against  concentration  gradient  at  the  cost  
ATP molecule liberating inorganic phosphate (pi). The inorganic phosphorous 
liberated is estimated by Fiske and Subbarow method. 
Reagents  
a) 184mM tris-HCl buffer, pH 7.5 
b) 50mM MgSO4 
c) 50mM KCl  
d) 600mM Nacl  
e) 1mM EDTA  
f) 40mM ATP 
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Procedure  
1ml of tris- HCl buffer and 0.2ml of each of the above reagents were mixed 
together. Thus, the assay medium in a final volume 2ml contained the above 
reagents. After 10mins, equilibration at 370C in an incubator, reaction was started by 
the addition of 0.1ml of homogenate. The assay medium was incubated for 15mins. 
After incubation, the reaction was arrested by the addition of 1.0ml of 10% TCA. 
The phosphorous content in the supernatant was estimated by Fiske and Subbarow 
method. The enzyme activity is expressed as µmoles of pi liberated/min/mg protein. 
Estimation of Mg2+-ATPase116 
Principle  
The activity of enzyme was estimated by the inorganic phosphorus liberated 
is estimated by Fiske and Subbarow method.  
Reagents   
a) 375mM Tris-HCl buffer, pH 7.6 
b) 25mM Mgcl2 
c) 10mM ATP 
Procedure  
The assay was carried out by the addition of 0.1ml of homogenate to an 
incubation medium containing 0.1ml of H2O  and  0.1ml  of  each  of  the  above  
reagents. The final concentration of above reagents were 75mM, 5mM and 2mM in 
total incubation volume of 0.5ml. the reaction was terminated after 15mins by the 
addition of 1ml of 10% TCA. The liberated phosphorous was estimated by Fiske and 
Subbarow method. The enzyme activity is expressed as µmoles of pi 
liberated/min/mg protein. 
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ESTIMATION OF LIVER GLYCOGEN117 
Principle  
Glycogen is treated with 45% ethanol to remove glucose. Glucose is 
dehydrated by sulphuric acid to furfural derivative which then complexes with an 
anthrone and give a green colored complex, which is read at 620nm. 
Reagents  
a) Extraction of Glycogen: 0.2g of the liver sample was homogenized with 20ml 
of 5% TCA. The precipitate of protein was filtered and the clear filtrate was 
used for analysis. 
b) Anthrone reagent: 0.2% anthrone in concentrated sulphuric acid 
c) Stock standard: 100mg of glucose dissolved in 100ml of H2O  
d) Working standard : 10ml of stock was made upto 100ml with  H2O 
e) 10N KOH = 56.11g of KOH in 100ml with  H2O  
f) Glacial acetic acid 
Procedure  
1ml  of  liver  sample  was  pippeted  out  into  a  test  tube.  Then  2ml  of  10N  
Potassium hydroxide was added and the test tube was placed in boiling water bath 
for 1hour. After cooling, 1ml of glacial acetic acid was added to neutralize the 
excess of alkali and the volume was made up to 10ml with water. From this 1ml was 
taken for the experiment. Glucose standards were prepared by taking 0.2 to 1ml with 
distilled H2O. Anthrone reagent (4ml) was added to all tubes and heated in boiling 
waterbath  for  8minutes,  cooled  and  absorbance  read  at  620nm.  The  amount  of  
glycogen present is expressed as mg/g tissue. 
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ESTIMATION OF DNA-DIPHENYLAMINE METHOD118, 119 
Principle  
Under extremely acidic conditions, DNA is initially de-purinated 
quantitatively followed by dehydration of sugar to omega-levulinyl aldehyde. This 
aldehyde condenses in acidic medium with diphenylamine to produce a deep blue 
coloured condensation product with absorption maximum at 600nm. 
Reagents  
a) DNA stock standard: 60mg of DNA was dissolved in 5mM NaOH and made 
up to 100ml with the same. 
b) Working standard: To 5ml of stock standard and 5ml of 0.2N perchloric 
acid was added and heated at 900C  for  15mins  and  cooled.  1ml  of  this  
solution contains 300µg of DNA.  
c) Saline citrate: 0.15M sodium chloride (8.78g/L) and 0.015M sodium citrate 
(4.41g/L) was mixed. 
d) Diphenylamine reagent: 1.5g of diphenylamine in 100ml of glacial acetic 
acid and 1.5ml of con. sulphuric acid. It was warmed to room temperature and 
swirled to remix before use. Stable for 6months at 20C.  
e) 0.6N perchlorate 
f) 0.2N perchlorate: 18ml of 70% perchloric acid was diluted to 250ml with 
water.  
g) 0.3M KOH 
h) 5% TCA  
i) 10% TCA 
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Procedure  
Sample preparation 
10 % liver homogenate was prepared; 5ml of 10% homogenate prepared was 
taken in a centrifuge tube. Then 2.5ml of 0.6N perchlorate was added and 
centrifuged for 10minutes at 00 C. The supernatant was discarded and the pellet was 
washed twice with 2.5ml of 0.2N perchlorate. The supernatant was discarded and to 
the pellet 4ml of ethanol was added and centrifuged for 10minutes at 370C. The 
supernatant was discarded again. 4ml of 0.3M Potassium hydroxide was added to 
the pellet and incubated for 1hour at 370C. Then 6ml of 0.2N perchlorate was added 
and centrifuged for 10minutes. The supernatant was used for DNA estimation and 
the pellet is further processed because it contained small amount of DNA. The pellet 
was washed twice with 5ml of 0.2N perchlorate and the supernatant was used for 
DNA estimation. To the pellet with 1.3ml of 10 % TCA was added and heated for 
15minutes at 900C, then centrifuged at 1500rpm for 10minutes. The supernatant was 
collected and labeled as supernatant 1. Then to the pellet 2.5ml of 5 % TCA was 
added and centrifuged for 10minutes. The supernatant was collected and labeled as 
supernatant 2. The supernatant 1 and 2 were pooled and the pellet was discarded. 
The supernatant final volume was made up to 5ml with saline citrate buffer and used 
for DNA estimation. 
Into a series of test tubes 0.2 to 1ml of the working standard DNA solution 
corresponding to 60-300µg values were pipette out. 1ml of the sample was pippeted 
out. The volume of all the tubes was made upto 2ml with distilled H2O. A blank was 
set up along with the working standard. 3ml of diphenylamine reagent was added to 
each  tube  and  after  mixing  the  tubes  were  heated  in  a  water  bath  for  10mins.  The  
tubes were removed and cooled by immersing them in tap water for 5mins. The 
absorbance of the blue solution was recorded at 600nm against blank. 
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ESTIMATION OF RNA BY ORCINOL METHOD120 
Principle  
The RNA content is estimated by orcinol method based on the estimation of 
ribose moiety of RNA, which produce a green colour with orcinol reagent. The 
intensity of the colour developed is proportional to the ribose content and is 
measured colorimetrically at 665nm. 
Reagents  
a) RNA stock standard: 100mg of purified RNA was dissolved in 10ml of 1N 
KOH. Incubated for 16-17hours at 370C and made up to 100ml in a 
standard flask with distilled water. 
b) Working standard: 10ml of the stock was diluted to 100ml. 1ml of this 
solution contains 100µg of RNA. 
c) Orcinol reagent: 0.34g of ferric chloride and 0.5g of orcinol were 
dissolved in a little amount of water and made up to 12.5ml with water. 
d) Dilute orcinol reagent: 12.5ml of stock was added to 225ml of conc. 
Hydrochloric acid and diluted to 250ml with water. 
Protocol  
Sample preparation  
10% liver homogenate was prepared; 5ml of 10 % homogenate prepared was 
taken in a centrifuge tube. Then 2.5ml of 0.6N perchlorate was added and 
centrifuged for 10minutes at 00C. The supernatant was discarded and the pellet was 
washed twice with 2.5ml of 0.2N perchlorate. The supernatant was discarded and to 
the pellet 4ml of ethanol was added and centrifuged for 10minutes at 370C. The 
supernatant was discarded again. 4ml of 0.3KOH was added to the pellet and 
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incubated for 1hour at 370C.  Then  6ml  of  0.2N  perchlorate  was  added  and  
centrifuged for 10minutes. The supernatant was used for RNA estimation and the 
pellet is further processed because it contained small amount of RNA. The pellet 
was washed twice with 5ml of 0.2N perchlorate and the supernatant was used for 
RNA estimation. 
0.2 to 1ml of the working standard RNA solution were pipette out into a 
series of test tubes corresponding to µg values 20 to 100. 0.5ml of the sample was 
pipetted out. The volume was made up to 2ml in all the tubes with distilled water. A 
blank  was  set  up  along  with  the  working  standard.  2ml  of  diluted  orcinol  reagent  
was added to all the tubes. The top of the tubes were covered with marbles and kept 
in a boiling water bath for 20mins. The tubes were removed and cooled at room 
temperature and the colour developed was read at 665nm in a spectrophotometer 
against the reagent blank. 
ESTIMATION OF GLUCOSE-ORTHOTOLUIDINE METHOD121 
Principle  
 Aldehyde group of glucose reacts with amino group of O-toluidine to give a 
green colored complex which can be read at 620nm in a colorimeter. The intensity 
of colour is proportion to the glucose concentration. The presence of thiourea 
stabilizes the  O-toluidine reaction.  
Reagents  
a) O-toluidine reagent – 0.3g of thiourea was made upto 155ml with glacial 
acetic acid. To this, 12ml of ortho-toluidine was added. 
b) Stock glucose: 2mg/ml 
c) Working standard: 1 in 10 dilution 
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Procedure  
0.5ml of sample and 4.5ml of 10% sodium tungstate reagent was taken in a 
test  tube,  mixed  well  and  the  contents  of  the  tubes  were  allowed  to  stand  for  
5minutes, centrifuged and to 0.5ml of supernatant 3ml of O- toluidine reagent was 
added. Into a series of test tubes, working standard glucose solution of concentration 
ranging 40-200µg were pipetted out. The green colour developed was read at 620nm 
in a colorimeter. 
Determination of tissue lipid peroxidation  
Lipid peroxidation is commonly observed as harmful process122 leading to 
structural modification of complex lipid protein assemblies, such as biomembranes 
and lipoproteins is usually associated with cellular malfunction. During lipid 
peroxidation a polar oxygen moiety is launched in the hydrophobic tails of 
unsaturated fatty acids. In this process presence of hydroperoxy groups affected the 
hydrophobic lipid/lipid and lipid/protein interaction which leads to structural 
modification of  biomembranes and lipoproteins. Hydroperoxy lipids are the source 
for the development of free radicals, when free radicals are produced they can attack 
poly unsaturated fatty acid in cell membrane leading to a chain of chemical reaction 
called lipid peroxidation. As the fatty acid is broken down, the hydrocarbon gases 
and aldehyde are formed. The measurement of malonodialdehyde (MDA) formed is 
the thiobarbituric acid assay method 123.  
1. Estimation of thiobarbituric acid reactive substances (TBARS) 109   
Principle  
The level of thiobarbituric acid reactive substances was estimated by the 
method of Nichans et al.,(1968). In this method, malondialdehyde and other 
thiobarbituric acid in the acidic medium generate a pink coloured chromophore, 
which is read at 535nm. 
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Reagents 
· TCA, 15% (w/v) 
· HCl, 0.25N 
· TBA, 0.375% in hot distilled water 
· TCA-TBA-HCl Reagent 
· Stock standard malondialdehyde solution 
· Working standard 
Stock solution was suitably diluted to get a concentration of 50nM/ml. 
Procedure  
0.5ml of homogenate was diluted to 1.5ml with double distilled water and 
mixed well. 2ml of TCA-TBA-HCl reagent was then added.  The mixture was kept 
in boiling water bath for about 15min. After cooling, the tubes were centrifuged at 
1000rpm for 10min and the supernatant was taken for colorimetric measurement at 
535nm using reagent blank. Molondialdehyde was used as a standard. The values 
were expressed as nM/g wet tissue.  
5.7.3 DETERMINATION OF IN VIVO ANTIOXIDANT LEVEL  
1. Assay of superoxide dismutase (SOD) 124 
Principle  
Superoxide dismutase activity was assayed by the method of Kakkar et al., 
(1984). The assay of SOD was based on the inhibition of the formation of NADH-
phenazine methosulphate-nitroblue tetrazolium complex.  The colour obtained is 
measured at 560nm. 
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Reagents 
· Sodium pyrophosphate buffer, 0.025M, pH 8.3 
· Phenazine methosulphate, 186mM 
· Nitroblue tetrazolium, 300mM 
· NADH-780mM 
· Glacial acetic acid 
· n-butanol 
· Chloroform 
· Ethanol 
Procedure  
0.5ml  of  the  sample  (tissue  homogenate)  was  diluted  to  1ml  with  ice  cold  
water. 2.4ml of ethanol and 1.5ml of CHcl3 (in chilled condition) were added.  This 
mixture  was  shaken  for  1min  at  4°C and then centrifuged. The enzyme activity in 
the supernatant was determined. 
 The assay mixture contained 1.2ml sodium pyrophosphate buffer, 0.1ml 
phenazine methosulphate, 0.3ml nitroblue tetrazolium, appropriately diluted enzyme 
preparation and water in a total volume of three milli litre. The reaction was initiated 
by the addition of 0.2ml NADH. After incubation at 30°C for 90sec, the reaction 
was stopped by the addition of 1ml glacial acetic acid. The reaction mixture was 
stirred vigorously and shaken with 4ml of n-butanol. The mixture was allowed to 
stand for 10min and then centrifuged. The colour intensity of the chromophore in 
butanol layer was measured at 560nm against n-butanol blank and a system devoid 
of enzyme served as control. One unit of enzyme activity is defined as the enzyme 
reaction which gave 50% inhibition of NBT reduction in one minute under the assay 
conditions and the activity was expressed as units/mg protein.  
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2. Assay of catalase (CAT) 125 
Principle:  
The activity of catalase was determined by the method of Sinha (1972). 
Dichromate in acetic acid was converted to perchromic acid and then to chromic 
acetate when heated in the presence of hydrogen peroxide.  The chromic acetate 
formed was measured at 620nm. Catalase was allowed to split hydrogen peroxide 
for different periods of time. The reaction was stopped at different time intervals by 
the addition of dichromate acetic acid mixture and the remaining hydrogen peroxide 
as chromic acetate is determined colorimetrically. 
Reagents 
· Phosphate buffer, 0.01M, pH 7.0 
· Hydrogen peroxide (H202) 0.2M 
· Potassium dichromate, 5% (w/v) 
· Dichromate acetic acid reagent  
· Standard hydrogen peroxide, 2mM 
Procedure: 
  To  6ml  phosphate  buffer,  0.1ml  sample  and  0.4ml  H2O2 were  added.  The  
reaction was stopped at 15, 30, 45 and 60s by the addition of 2ml dichromate-acid 
reagent. The tubes were kept in boiling water both for 10min and the colour 
developed was read at 620nm. Standards in the range of 2-10mM were taken and 
proceed similar to the test with blank containing reagent alone. The activities were 
expressed as mM of H2O2 consumed/ minute/ mg protein.  
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3. Assay of glutathione peroxidase (Gpx) 126 
Principle:  
Glutathione peroxidase activity was estimated by the method of Rotruck et 
al., 1973. A known amount of enzyme preparation was allowed to react with H2O2 
in the presence of GSH for a specified time period and the remaining GSH content 
was measured.  
    Gpx 
 2GSH+H2O2                     GSSG+2H2O 
Reagents  
· Tris buffer, 0.4M, pH 7.0 
· Sodium azide solution, 10mM 
· Tricholoro acetic acid, 10% (w/v) 
· EDTA, 0.4mM 
· H2O2 solution, 20mM 
· Glutathione solution, 2mM 
Procedure:  
The mixture containing tris buffer, EDTA, sodium azide, sample (tissue 
homogenate), and hydrogen peroxide were incubated at 37°C for 10min along with a 
tube  containing  all  the  reagents  except  the  sample.  After  10min,  the  reaction  was  
arrested by the addition of 0.5ml of 10% TCA, centrifuged and the supernatant was 
assayed for GSH by the method of Beutler et al., 1963. 
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4. Estimation of glutathione (GSH) 127 
Principle: 
Glutathione level was estimated by the method of Ellman et al., 1959 in 
which, yellow colour developed when dithio-dinitro-bis-benzoic acid (DTNB) is 
added to the compounds containing sulphydryl groups and measured 
colorimetrically. 
Reagents 
·  Phosphate buffer, 0.2M, pH 8.0  
·  TCA, 5%(w/v) 
·  Ellman's reagent 
·  Disodium hydrogen phosphate (Na2HPO4 ). 0.3M, pH 8.0 
·  Standard glutathione solution 
·  Precipitating reagent 
Procedure:  
A known weight of tissue was homogenized in phosphate buffer. To 0.5ml of 
the sample, 3ml of precipitating reagent was added, mixed thoroughly and allowed 
to stand for 5min and centrifuged. A set of standards (20-100mg) were taken and 
made upto 2ml with distilled water. 2ml of the supernatant along with 2ml of blank 
containing distilled water was also taken. To all the tubes 4ml of 0.3M disodium 
hydrogen phosphate and 1ml of DTNB reagent were added. The colour developed 
was read at 412nm. The reduced glutathione levels were expressed as mg/g wet 
tissue.  
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5. Estimation of protein128 
Principle  
The  protein  content  was  estimated  by  the  methods  of  Lowry et al., (1951). 
Proteins react with Folin-Ciocalteau reagent to give a complex. The colour so 
formed was due to the reaction of alkaline copper with protein and the reduction of 
phosphomolybdate by tyrosine and trytophan present in the protein. The intensity of 
the blue colour depends on the amount of these aromatic amino acids present. 
Reagents  
·  Alkaline copper reagent 
·  Folin’s phenol reagent          
·  Standard bovine serum albumin (BSA)                       
Procedure  
0.1ml of homogenate was made upto 1ml with saline, then 1ml 10% TCA 
was added. The mixture was centrifuged, supernatant discarded and the precipitate 
was dissolved in 1ml of 0.1N sodium hydroxide. From this aliquots were taken for 
the estimation. 4.5ml of alkaline copper reagent was added and the contents were 
allowed to stand at 37 ̊C for 10min. Then 0.5ml dilute Folin’s phenol reagent was 
added and mixed. A series of standards of concentration range 20-100mg and a blank 
were processed as for the test. The blue colour developed was read at 620nm after 
20min.  
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6. Estimation of Vitamin E (α-Tocopherol) 129 
Principle  
Vitamin E levels were estimated by the method of Baker et al (1980). This 
method involves the reduction of ferric ions to ferrous ions by tocopherol and the 
formation of a pink coloured complex with 1, 10-phenanthroline-ortho phosphoric 
acid.  The  reaction  mixture  consist  of  redistilled  ethanol,  petroleum  ether,  4,  7-
dipyridyl-1-10-phenanthroline, 0.01M ferric chloride and 0.001M Ortho phosphoric 
acid. The red colour developed was measured at 520nm. The vitamin E values were 
expressed as mg/100mg tissue for tissues. 
Reagents 
· Petroleum ether :  60- 80 °C 
· Double distilled ethanol. 
· 2, 2’ dipyridyl solution: 0.2% in double distilled ethanol. 
· Ferric chloride solution: 0.5% in double distilled ethanol. 
· Stock standard: 10mg of a – tocopherol in 100ml of distilled ethanol. 
· Working standard: Stock solution was diluted with ethanol to a concentration 
of 10mg/ml. 
Procedure 
To 0.5ml of sample, 1.5ml of ethanol was added, mixed and centrifuged. The 
supernatant was evaporated and to the precipitate, 3.0 ml of petroleum ether, 0.2ml 
of 2, 2’ dipyridyl solution and 0.2ml of ferric chloride solution were added and kept 
in dark for 5min. An intense red colour was developed. 4ml of n-butanol was added 
to all the tubes and mixed well. Standard a -tocopherol in the range of 10-100mg 
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was taken and treated similarly along with a blank containing only the reagent. The 
colour in the n-butanol layer was read at 520nm. The values were expressed as 
mg/dl for plasma or mg/100g of wet tissue. 
7. Estimation of Vitamin C130 
Principle  
Vitamin C was measured by the method of Roe and Kuether (1943).  The 
ascorbic acid was converted to dehydroascorbic acid by mixing with norit and then 
coupled with DNPH in the presence of thiourea. The coupled DNPH was converted 
in to a red colour compound with sulphuric acid and it was measured at 540nm. 
vitamin c values measured as mg/dl. 
Reagents 
· TCA: 6% 
· 2, 4 DNPH reagent: 2g of DNPH was dissolved in 100ml of 9N sulphuric 
acid. To this, 4g of thiourea was added and mixed. 
· Sulphuric acid : 85% 
· Stock ascorbic acid solution: 10mg of L-ascorbic acid in 100ml of 4% 
TCA. 
· Working ascorbic acid solution: 1 in 10 dilution of stock ascorbic acid 
solution with 4% TCA to obtain a concentration of 0.1mg/ml. 
Procedure 
To 0.5ml of sample, 1.5ml of 4% TCA was added and allowed to stand for 
5min and centrifuged. To the supernatant, 0.3g of acid washed norit was added, 
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shaken vigorously and filtered. This converts ascorbic acid to dehydroascorbic acid. 
0.5ml of the filtrate was taken and 0.5ml of DNPH reagent was added, stoppered and 
placed in a water bath at 37°C  for  exactly  3h.  It  was  removed,  placed  in  ice-cold  
water and 2.5ml of 85% sulphuric acid was added drop by drop. The contents of the 
tubes were mixed well and allowed to stand at room temperature for 30min. A set of 
standards containing 20-100mg of ascorbic acid were taken and processed similarly 
along  with  a  blank  containing  2ml  of  4%  TCA.  The  color  developed  was  read  at  
540nm. The values were expressed as mg/dl of plasma or mg/100g of wet tissue. 
STATISTICAL ANALYSIS 
 The results were expressed as mean ± SEM or mean ± SD. One way analysis 
of variance (ANOVA) followed by Duncan multiple comparison test method was 
used to correlate the difference between the variables. P<0.05 was considered as 
statistically significant.  
5.7.4 HISTOPATHOLOGICAL STUDIES   
 When the tissues are exposed to any toxicants, alterations in the tissue 
architecture are more prominent. This can be monitored by histochemical 
examination131. 
TISSUE PROCESSING  
A fraction of the tissues was fixed in 10% formalin immediately after 
autopsy. The fixed tissues were placed in (10% formalin in 0.9% Nacl) for one hour 
to resolve shrinkage due to higher concentration of formalin solution. They were left 
overnight in running water after securing the mouths of the vessels with cotton 
gauze. The tissues were dehydrated in ascending grades of isopropanol (by 
immersing in 80% isopropanol overnight followed by 100% isopropanol for one 
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hour. The dehydrated tissues were cleared in two changes of xylene, one hour each. 
Then the tissues were drenched with histology grade paraffin wax (melting point  
58-600 C). The wax impregnated tissues were implanted in paraffin blocks using the 
same grade wax. The paraffin blocks were mounted and cut with rotary microtome 
at three micron thickness. The sections were drift on a tissue flotation bath at 400C 
and taken on a glass slide smeared with equal parts of egg albumin and glycerol. The 
sections were then melted in an incubator at 600C and allowed to cool for 5minutes. 
TISSUE STAINING 
The sections were deparaffinised by dipped in xylene for 10minutes in a 
staining jar. The deparaffinised sections were washed in hundred percentage of 
isopropanol and stained in Ehrlich’s haematoxylin for 8minutes. After staining in 
haematoxylin, the sections were washed in tap water and immersed in acid alcohol 
(8.3% HCl in 70% alcohol) to remove excess stain. The sections were counter-
stained with 1% aqueous solution of eosin for 1minute. The excess stain was washed 
in tap water and the section was allowed to dry. Complete dehydration of the stained 
section was ensured by placing the section in an incubator at 600C for 5minutes. 
When the sections were cooled, they were mounted in DPX mountant. The cell 
architecture in the liver was observed under high power objective in a microscope.  
5.8   ISOLATION AND CHARACTERIZATION 
5.8.1 THIN LAYER CHROMATOGRAPHY (TLC) STUDY 
TLC characterization of WPC    
Chromatography is the separation of mixture of compounds into individual 
compounds using a mobile phase and stationary phase. The principle of separation is 
either partition or adsorption. The constituent which is having more affinity for 
mobile phase moves with it, while the constituent which is having more affinity for 
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stationary phase gets adsorbed on it. This way various compounds appear as a band 
on the TLC plate, having different Rf values. The EEPC was subjected to TLC study 
for the separation and identification of its components. 
TLC is an important analytical tool in the separation, identification and 
estimation of different classes of natural products. This technique allows the 
separation of different components by the differential migration of solute between 
two phases (stationary phase and mobile phase). The main principle involved in this 
technique is adsorption chromatography. 
Preparation of plates  
Hundred grams of silica gel G was weighed and made into a homogenous 
suspension with 200ml of distilled water to form slurry. The slurry was added into a 
TLC applicator, which was adjusted to 0.25mm thickness on flat glass plate of 
different dimensions (10X2, 10X5, 30X5, 20X10 cm etc,). The coated plate was 
allowed to dry in air, followed by heating at 100 to 105°C for one hour, cooled and 
protected from moisture. Before using, the plate was activated at 110°C for ten 
minutes. 
Separation of components   
The ethanol extract of the plant was dissolved in methanol separately and 
spotted using a capillary tube on TLC plates 2cm above from the bottom of the 
plate. 
Selection of a mobile phase 
 The selection of a mobile phase depends upon various factors as mentioned 
below: 
Chapter 5      Materials and Methods 
77 
 
v Nature of substance to be separated 
v Nature of stationary phase 
v Chromatographic mode 
 The selection of solvent systems was based on increasing the order of 
polarity.  The  different  spots  developed  in  each  system  were  detected  by  means  of  
iodine staining.  
5.8.2 COLUMN CHROMATOGRAPHY132 
Column chromatography is an isolation technique in which the 
phytoconstituents are being eluted by adsorption. The principle involved in this 
separation of constituents is adsorption at the interface between solid and liquid. The 
component must have various degree of affinity towards adsorbent and also 
reversible interaction to achieve successful separation. No two compounds are alike 
in  the  above  aspect.  Low  affinity  compounds  will  elute  first.  The  columns  of  
different sizes were used for the present studies. 
Since the EEPC was found to possess significant pharmacological activity 
when compared to other extracts an attempt was made to fractionate the ethanol 
extract by column chromatography. 
Materials and Methods 
Type of extract: Ethanol extract 
Method: Wet packing method 
Packing material: Silica gel G 70 – 325. 
The EEPC was placed to column chromatographic separation using normal 
phase silica gel column. 
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Preparation of Admixture 
20g of EEPC was admixed with 20g of silica gel (60/120 meshes) to get 
uniform mixing.  
Column packing    
 Two hundred gram of silica gel (70/325 meshes) was taken in a suitable 
column and packed very carefully without air bubbles using hexane as filling 
solvent. The column was kept aside for one hour and allowed for close packing. 
Admixture was then introduced at the top of the stationary phase and started 
separation of compounds by the eluting with various solvent mixtures with 
increasing order of polarity. All the column fractions were collected separately and 
concentrated under reduced pressure. Finally the column was washed with ethyl 
acetate and methanol.  
The EEPC was subjected to column chromatographic separation using 
normal  phase  silica  gel  column.  The  dark  brown  solid  (20gram  of  EEPC)  was  
adsorbed on silica gel (20g) and transferred to a column of silica gel (200g 
equilibrated with n-hexane). Elution was performed with n-hexane (100%), n-
hexane: chloroform (90:10), n-hexane: chloroform (70:30), n-hexane: chloroform 
(50:50), n-hexane: chloroform (30:70), chloroform (100), chloroform: ethyl acetate 
(70:30), chloroform: ethyl acetate (50:50), chloroform: ethyl acetate (30:70), ethyl 
acetate (100), ethyl acetate: methanol (80:20), ethyl acetate: methanol (70:30) ethyl 
acetate: methanol (50:50), ethyl acetate: methanol (30:70) and methanol(100).  
Fractions were collected, distilled off the solvent and the homogeneity of the 
resulting residues was examined on TLC by using different solvent systems and 
similar fractions, identified by their TLC behavior mixed together. 
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       Fractions 27-61 eluted with n-hexane: Chloroform (70:30), fractions 73-95 
eluted with ethyl acetate: methanol (50:50).  Fractions 27-61 eluted with n-hexane: 
Chloroform (70:30) gave a solid designated as compound 1 (125mg), fractions 73-
95 eluted with ethyl acetate: methanol (50:50) gave a solid designated as compound 
2 (168mg).  
5.8.3 CHARACTERISTIC ANALYSIS OF THE ISOLATED COMPOUNDS 
FROM EEPC USING VARIOUS ANALYTICAL TECHNIQUES132 
The isolated compounds 1-2 were characterized and identified by IR, NMR 
and GC-MS spectrophotometric methods and chemical structure of the compounds 
were subsequently elucidated. 
Spectral analysis of the compounds using FT-IR 
The FT-IR spectra of the isolated compounds from the WPC by using 
Nicolet 170SX. The spectral resolution for the Nicolet 170SX was 0.25cm-1, and the 
spectral data were stored in the database at intervals of 0.5cm-1 at 2000-4000cm-1, 
and of 0.25cm-1 at 2000-400cm-1. The samples were measured by using KBr disc 
methods.  
Spectral analysis of the compounds using 1H NMR 
The 1H NMR spectra of the isolated compounds from the WPC was obtained 
by using a JEOL AL-400 (399.65 MHz). The measuring conditions for most of the 
spectra were as follows: flip angle of 22.5 - 30 degrees, pulse repetition time of 30s. 
The long pulse repetition time and small flip angle was used to ensure precise 
relative intensities. The 1H NMR chemical  shifts  were  referred  to  TMS in  organic  
solvents and TSP in D2O.  
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Spectral analysis of the compounds using 13C NMR 
The 13C NMR spectra of the compounds isolated from the WPC by using a 
Bruker AC-200 (50.323 MHz). The measuring conditions for the most of the spectra 
were as follows: a pulse flips angle of 22.45-45degrees, a pulse repetition time of   
4-7seconds, and a resolution of 0.025-0.045ppm. The chemical shift was referred to 
a TMS for all solvents.  
Spectral analysis of the compounds using GC-MS 
Mass spectra of the compounds isolated from the WPC by using a JEOL 
JMS-700 by the electron impact method where an electron is accelerating voltage 
75eV and an ion accelerating voltage of 8-10nV. The reservoir inlet systems were 
used. The dynamic range for the peak intensities were 3 digits and the accuracy of 
the mass number was 0.5.  
5.9 IN VITRO ANTIOXIDANT AND CYTOTOXICITY FOR ISOLATED 
COMPOUNDS 
The isolated compound 1 namely 6- methoxyflavone and compound 2 
namely 3, 5, 7- trihydroxy-2-(4-methoxyphenyl) - 4H - chromen – 4 – one from 
EEPC was evaluated for in vitro anti-oxidant (DPPH, superoxide radical scavenging 
and nitric oxide scavenging activity) and anti cancer [human cancerous liver cell 
lines (HepG2), human colon cancer cell lines (HT29)] activity by the method 
adopted for screening of the extracts.  
5.10 P53 GENE EXPRESSION FOR ISOLATED COMPOUNDS IN HepG2 
CELLS. 
The P53 gene expression for isolated compounds was studied by using 
HepG2 cells. The total RNA was isolated from HepG2 cells for real time-PCR 
analysis of p53 genes133. HepG2 cells were cultured for 24h then incubated for 48h 
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with fresh medium containing isolated compounds (test cells) or 1% DMSO (control 
cells). The concentrations of compound 1 and compound 2 used were 2.50, 7.50 and 
10.45µg/ml and triplicate cell cultures were exposed to each concentration. The 
quantity and quality of the extracted RNA were determined by measuring the 
absorbance at 230, 260 and 280nm of the spectrophotometer and 2 characteristic 
bands  of  RNA  were  appeared  by  gel  electrophoresis.  The  primers  were  obtained  
from  NCBI  site  and  real-time  PCR  was  performed  by  using  Syber  Green  dye.  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was preserved as a reference 
gene. 
Primer sequences for real time-PCR.  
Name of 
gene 
Primer forward Primer reverse 
p53 TGAGGTGCGTGTTTGTGCCTGT  TCGGAACATCTCGAAGCGCTCA 
GAPDH                                                       GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTT 
 
Determination of p53 gene expression by flow cytometry133 
 The test and control cells were fixed with 4% paraformaldehyde (10 min) 
and then permeabilized with 0.1% PBS-Tween for 20min133.  The  cells  (2x105 
cells/ml) were incubated in 1-fold PBS/ 10% normal goat serum/ 0.3mol/L glycine 
to block non-specific protein-protein interactions followed by the Anti-p53 antibody 
[DO-1] (USA) for 30min at 220C and then analyzed using FAC Star caliber (Becton 
Dickinson). 
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CHAPTER 6 
RESULTS AND ANALYSIS 
6.1 EXTRACTION OF DRIED POWDER OF WPC	
The WPC was collected from Tirunelveli District, Tamil Nadu, India and 
plant authentication was done by the Botanical survey of India. The WPC was dried 
under shade, segregated, pulverized by a mechanical grinder and passed through a 
40 mesh sieve. The dried powder of WPC was extracted sequentially by hot 
continuous percolation method using Soxhlet apparatus, using different solvents like 
petroleum ether, ethyl acetate and ethanol. The resultant extracts were concentrated 
by using a rotary evaporator and subjected to freeze drying in a lyophilizer till dry 
powder was obtained. The extracts were stored in screw cap vials at 4°C until 
further use. The percentage yields of the WPC are shown in Table 1. 
Table 1: Extractive values of the WPC 
Plant name Parts used 
Method of 
extraction Solvent system 
Percentage yield 
(%w/w) 
P.corymbosa Whole 
plant 
Continuous 
Hot 
Percolation 
Petroleum ether 
Ethyl acetate 
Ethanol  
9.87 
7.88 
16.56 
6.1.1 PRELIMINARY PHYTOCHEMICAL SCREENING  
The various extracts of WPC were  subjected  to  analysis  for  its  
phytochemical constituents. The phytochemical screening results are shown in 
Table  2.The PEEPC  contains phytosterols, fixed oils & fats. EAEPC contains 
alkaloids, carbohydrates,  glycoside, phenolic compounds, tannins, protein and  
amino acids, saponins, fixed oils and fats. The EEPC contains alkaloids, 
carbohydrates, glycoside, saponins, phenolic compounds, tannins, protein and 
aminoacid & flavonoids.  
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Table 2: Phytochemical analysis of various extracts of P.corymbosa 
S.No. Test Petroleum ether 
Ethyl 
acetate Ethanol 
I Alkaloids - + + 
II Carbohydrates and glycosides - + + 
III Phytosterols + - - 
IV Fixed oil and fats + + - 
V Saponins - + + 
VI Phenolic compounds and tannins - + + 
VII Protein and Amino Acid - + + 
VIII Gum and Mucilage - - - 
IX Test for flavonoids - - + 
+ Positive 
- Negative 
6.2 In vitro ANTIOXIDANT ACTIVITY  
The petroleum ether, ethyl acetate and ethanol extracts of the WPC were 
subjected to in vitro antioxidant activity. 
6.2.1 DPPH radical scavenging activity of the extracts 
The results obtained for the DPPH radical scavenging activity of the extracts 
of the WPC are presented in Table 3 and Fig. 3.  
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Table 3: DPPH scavenging potential of various extracts of WPC 
S. 
No 
Conc. in 
µg/ml 
% scavenging * 
Pet ether 
extract 
Ethyl acetate 
extract 
Ethanolic 
extract 
Standard 
(Rutin) 
1 125 12.64 ± 0.03 14.61 ± 0.04 38.65 ± 0.16 28.39 ± 0.25 
2 250 14.43 ± 0.09 19.58 ± 0.06 56.51 ± 0.03 48.98 ± 0.46 
3 500 25.45 ± 0.30 25.97 ± 0.27 59.76 ± 0.18 65.18 ± 0.13 
4 1000 47.53 ± 0.02 53.45 ± 0.14 72.02 ± 0.43 70.65 ± 0.20 
IC50 (µg/ml) 1250 875 225 270 
 * Results are expressed as mean ± SEM for three estimations 
Fig 3: DPPH scavenging potential of various extracts of WPC 
 
From Table  3 and Fig. 3, it was observed that the maximum scavenging 
activity at 1000µg/ml and IC50 value  of  PEEPC was  found  to  be  47.53%  and  
1250µg/ml, and for EAEPC, it was found to be 53.45% and 875µg/ml while for 
EEPC  it was found to be 72.02% and 225µg/ml respectively  and  that of standard 
rutin  was found to be 70.65% and 270µg/ml respectively. 
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6.2.2  Inhibition of superoxide anion radical  
The results obtained for superoxide anion radical scavenging potential of the 
extracts of WPC are presented in Table 4 and Fig. 4.  
Table 4: Superoxide anion radical inhibition assay of various extracts of WPC 
S. No 
Conc. 
in  
µg/ml 
% inhibition * 
Petroleum 
ether extract 
Ethyl acetate 
extract 
Ethanolic 
extract 
Standard 
(Quercetin) 
1 125 13.26 ± 0.48 21.87 ± 0.33 51.11 ± 0.50 49.44 ± 0.48 
2 250 25.17 ± 0.42 33.84 ± 0.58 68.22 ± 0.11 61.88 ± 0.49 
3 500 32.06 ± 0.52 40.67 ± 0.22 81.10 ± 0.31 78.39 ± 0.18 
4 1000 39.14 ± 0.43 49.42 ± 0.15 94.41 ± 0.03 89.28 ± 0.09 
IC50 in µg/ml 1365 1005 110 145 
 * Mean ± SEM for 3 determinations 
Fig 4: Superoxide anion radical scavenging potential of various extracts of 
WPC
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From Table  4 and Fig. 4, it was observed that the maximum superoxide 
radical scavenging activity at 1000µg/ml and IC50 value of PEEPC was found to be 
39.14% and 1365µg/ml, for EAEPC it was found to be 49.42% and 1005µg/ml 
while for EEPC, it was found to be 94.41% and 110µg/ml respectively and that of 
standard quercetin  was found to be 89.28% and 145µg/ml respectively.  
6.2.3  Nitric oxide radical inhibition assay 
The results obtained for nitric oxide radical scavenging potential of the 
extracts of the WPC are presented in Table 5 and Fig. 5.  
Table 5: Nitric oxide anion radical scavenging potential of various extracts of 
WPC 
S. No 
Conc. 
in  
µg/ml 
 
 
% inhibition * 
 
Petroleum 
ether extract 
Ethyl acetate 
extract 
Ethanolic 
extract 
Standard 
(Ascorbic 
acid) 
1 125 18.26±0.09 13.36±0.16 39.20±0.02 26.87 ± 0.08 
2 250 24.39±0.19 17.71±0.50 49.73±0.29 30.30 ± 0.05 
3 500 33.42±0.27 40.12±0.43 61.29±0.70 60.64 ± 0.02 
4 1000 39.41±0.14 45.49±0.16 69.65±0.05 65.23 ± 0.01 
IC50 in µg/ml 1320 1090 255 410 
      * Mean ± SEM of triplicate determinations 
 From Table 5 and Fig. 5, it was observed that the maximum of nitric oxide 
radical scavenging activity at 1000µg/ml and IC50 value of PEEPC was found to be 
39.41% and 1320µg/ml, for EAEPC, it was found to be 45.49% and 1090µg/ml and 
for EEPC, it was found to be 69.65% and 255µg/ml respectively while for standard 
ascorbic acid,  it was found to be 65.23% and 410µg/ml respectively.  
Chapter  6          Results & Analysis 
87 
Fig 5: Nitric oxide anion radical inhibition assay of various extracts of WPC 
 
6.2.4 Hydroxyl radical scavenging activity 
The results obtained for hydroxyl radical inhibition assay of the extracts of 
the WPC are presented in Table 6 and Fig. 6.  
From Table  6 and Fig. 6, it was observed that the maximum of hydroxide 
radical scavenging activity at 1000µg/ml and IC50 value of PEEPC was found to be 
29.48% and 1480µg/ml, for EAEPC, it was found to be 65.36% and 595µg/ml and 
for EEPC it was found to be 82.58% and 265µg/ml respectively, while that of 
standard rutin was found to be 75.23% and 280µg/ml.  
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Table 6: Hydroxyl radical inhibition potential of various extracts of WPC 
S. 
No 
Conc. 
in  
µg/ml 
 
 
% inhibition * 
 
Petroleum ether 
extract 
Ethyl acetate 
extract 
Ethanolic 
extract 
Standard 
(Rutin) 
1 125 13.26 ± 0.47 23.66 ± 0.04 40.36 ± 0.07 26.87 ± 0.09 
2 250 18.47 ± 0.96 29.78 ± 0.93 49.63 ± 0.31 40.38 ± 0.08 
3 500 25.66 ± 0.92 40.66 ± 0.22 53.74 ± 0.97 71.64 ± 0.43 
4 1000 29.48 ±0.07 65.36 ± 0.02 82.58 ± 0.11 75.23 ± 0.02 
IC50 in µg/ml 1480 595 265 280 
* Expressed as mean ± SEM for three estimations. 
Fig 6: Hydroxyl radical scavenging potential of various extracts of WPC 
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6.2.5 Total phenolic and flavonoid content  
The results obtained for total phenolic and flavonoid content of various 
extracts of the WPC are depicted in Table 7 and Fig. 7.   
The phenolic and flavonoid content in EEPC was found to 4.60 ± 0.05mg 
and 3.63 ± 0.93mg respectively which was higher than that present in other extracts. 
Table 7: Total phenol and flavonoid content of various extracts of WPC 
S. 
No 
Name of the Extract 
Total phenol content 
(mg/g of Gallic acid) 
(±SEM)* 
Total flavonoid content 
(mg/g of Catechol) 
(±SEM)* 
1 Petroleum ether extract  1.94 ± 0.22 0.97 ± 0.06 
2 Ethyl acetate extract 2.04 ± 0.73 1.70 ± 0.09 
3 Ethanol extract  4.60  ± 0.05 3.63 ± 0.93 
 * Values expressed as mean ± SEM for three estimations. 
Fig 7: Total phenolic and flavonoid content of various extracts WPC 
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6. 3 In vitro CYTOTOXICITY  
6.3.1 Percentage growth inhibition of different cell lines by various extracts of 
WPC 
 The results obtained for inhibition of the growth of various cell lines by 
various extracts of the WPC are shown in Table 8 and Fig.8and 14-28.    
The results obtained for inhibition of the growth of different cell lines by 
doxorubicin are shown in Fig.9-13.  
Table 8:Cytotoxic activity (IC50 values) of different cell lines by various extracts 
of WPC 
S. 
No. 
Treatment 
Conc. 
in 
μg/ml 
Cell lines  * 
MCF-7 HL-60 HepG2 HT29 PC3 
1 PEEPC 100 >100 >100 >100 97.55±0.75 >100 
2 EAEPC 100 28.05±0.02 91.55±0.01 85.55±0.71 82.69±0.05 98.02±0.05 
3 EEPC 100 6.80±0.05 11.50±0.45 10.00±0.02 7.05±0.60 17.20±0.85 
4 DXN 100 6.50±0.07 10.25±0.93 10.78±0.10 7.25±0.11 16.47±0.24 
*Mean ± SEM of 3 independent analysis 
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Fig: 8 Cytoxic activity (IC50 values) of different cell lines by various extracts of 
WPC 
 
Doxorubicin and EEPC were active on all cell lines (MCF-7, HL-60, HepG2, 
HT-29  and  PC3).  The  IC50 value of EEPC on  various  cell  lines  like  MCF-7  
(6.80±0.05), HL-60 (11.50±0.45),HepG2 (10.00±0.02), HT-29 (7.05±0.60) and PC3 
(17.20±0.85) are shown in Fig. 24-28. The EAEPC was found to be moderately 
active on MCF-7 (28.05±0.02) cell line and inactive on HL-60, HepG2, HT-29 and 
PC3 cell lines (Fig. 19-23). On the other hand PEEPC was not found to be active on 
all cell lines (Fig. 14-18). 
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Effect of Doxorubicin on various cell lines by MCF-7, HL-60, Hep G2, HT-29 
and PC3 
Fig: 9  MCF-7 cell  line Fig: 10   HL-60 cell  line 
  
Fig: 11   Hep G2 cell line Fig:12   HT-29 cell line 
  
Fig:13 PC3 cell line 
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Effect of PEEPC on different cell lines 
Fig: 14   MCF-7 cell line Fig: 15    HL-60  cell line 
  
Fig: 16   Hep G2 cell line Fig: 17   HT-29 cell line 
  
Fig: 18   PC3 cell line 
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Effect of EAEPC on different cell lines 
Fig: 19  MCF-7 cell line Fig: 20  HL-60 cell line 
  
Fig: 21  Hep G2 cell line Fig: 22   HT-29 cell line 
  
Fig: 23   PC3 cell line 
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Effect of EEPC on different cell lines 
Fig:24   MCF-7 cell line Fig: 25    HL-60 cell line 
  
Fig: 26  HepG2 cell line 
 
Fig: 27  HT-29 cell line 
 
  
Fig: 28  PC3 cell line 
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6.4 ACUTE ORAL TOXICITY (AOT) RESULTS 
The AOT  studies of various extracts of the WPC was carried out as per 
OECD-423 guidelines as presented in Fig. 2 
The results of AOT revealed  that  LD50 values of various extracts of WPC 
whole plant were high and apparently showed the safety of those extracts.  
The results of general behavioural studies in mice after administration of 
various extracts of WPC whole plant are presented in Table 9.  
Table 9: Results of general behavioural studies in mice on administration of 
various extracts of WPC   
S. 
No. 
Parameters Pet ether extract 
Ethyl acetate 
extract 
Ethanolic 
Extract 
1 Motor activity Absent Absent Absent 
2 Tremors Absent Absent Absent 
3 Convulsion Absent Absent Absent 
4 Straub reaction Absent Absent Absent 
5 Pile erection Absent Absent Absent 
6 Loss of light reflex Absent Absent Absent 
7 Sedation Absent Absent Absent 
8 Muscle relaxation Absent Absent Absent 
9 Hypnosis Absent Absent Absent 
10 Analgesia Absent Absent Absent 
11 Ptosis Absent Absent Absent 
12 Lacrimation Absent Absent Absent 
13 Diarrhoea Absent Absent Absent 
14 Change in skin colour No change No change No change 
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From Table 9, it can be observed that the treatment of mice with various 
extracts of the WPC showed no changes in the autonomic or behavioural responses. 
Zero percent mortality was obtained for various extracts of the WPC and hence the 
extracts were found to be nontoxic upto the dose of 2000mg/kg. 
6.5  ANTICANCER STUDY 
 Anticancer activity was investigated for the various extracts of WPC. 
6.5.1 Animal body weight, Mean survival time(MST), percentage increase in 
life span,  tumor volume, PCV and  tumour cell count. 
Animal body weight, Mean survival time(MST), percentage increase in life 
span, tumour volume, PCV and tumour cell count  were observed for different 
extracts of the WPC are depicted in Table 10 and Fig.29-33. 
It can be seen from Table 10 and Figs. 29-33,that animals treated with EAC 
alone showed an increased in body weight, decrease in Mean survival time and 
percentage increase in life span, increase in tumour volume, PCV and  viable cell 
count than the plant extract treated Group.   
Post treatment with EEPC and standard drug (5-FU) significantly reduced 
the weight gain of animals in group V and VI.  Similar result was not found in other 
extracts treated animals (group III & IV). Tumor mice died after 18 days of 
inoculation whereas the life span of group V and VI mice was observed for six  
weeks. In EAC bearing mice, the ascitic volume and viable cell count was found to 
be increased. Supplementation of WPC reverses the above alterations and 
incremented the non-viable cell count indicating its cytotoxicity towards cancer 
cells. 
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Table 10:  Body weight, Mean survival time, Percentage increase in life span, 
Tumor volume, PCV and Tumor cell count of various experimental animals 
treated WPC extracts 
Groups 
Bodyweight 
(gm) 
Mean 
survival 
time 
(days) 
% in 
life 
span 
Tumour 
volume 
Packed 
cell 
volume 
Tumour cell count 
(1X 107 cells/ml). 
Viable Non- 
viable 
EAC 
control 
36.10 ± 0.58 
17.08 ± 
0.68 
__ 
2.81 ± 
0.11 
1.3 ± 
0.10 
11.82  
± 0.92 
0.34 ± 
0.02 
EAC + 200 
mg of 
PEEPC 
33.20 ± 0.27 
18.61 ± 
0.98 
28.06 
2.67 ± 
0.08 
1.1 ± 
0.81 
10.32 ± 
0.87 
0.38 ± 
0.11 
EAC + 200 
mg of 
EAEPC 
29.91 ± 0.07 
20.19 ± 
0.71 
37.48 
2.10 ± 
0.09 
0.98 ± 
0.17 
9.11 ± 
0.25 
0.51 ± 
0.22 
EAC + 200 
mg of 
EEPC 
26.91 ± 0.91 
29.18 ± 
0.91 
59.67 
1.90 ± 
1.16 
0.53 ± 
0.07 
7.62 ± 
0.25 
0.68 ± 
0.03 
EAC + 
20mg of  5- 
FU 
26.45 ± 0.16 
32.17 ± 
2.01 
86.93 __ __ __ __ 
Ø Values are expressed as mean ± SD for 6 mice in each group.  
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Fig: 29 Effect of  WPC  plant extracts on body weight 
 
 Fig: 30 Mean Survival Time of various experimental animals treated with 
WPC 
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Fig: 31 Percentage increase in life span of various experimental animals 
treated with WPC 
 
Fig: 32 Tumour volume of various experimental animals treated with WPC 
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Fig: 33 Packed Cell Volume of animals treated with WPC 
 
6.5.2 Haematological Parameters 
The haematological parameters namely RBC, Hb, Total WBC count and 
differential count were observed for various extracts of the WPC as furnished in 
Table 11& 12 and Fig 34-37.  
The EDTA-anticoagulated blood was analyzed for the abnormalities of 
haematological parameters namely RBC, Hb, Total WBC count and differential 
count. In group II mice, RBC, Hb, Lymphocytes and monocytes were found to be 
decremented whereas total WBC count and neutrophilis were observed to be 
incremented. EEPC and 5-Fluorouracil administration to EAC bearing animals has 
restored  RBC,  Hb,  total  WBC count  and  differential  count  to  a  significant  extent.  
This indicates the protective nature of the extract on the haematopoietic system. 
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Table 11: Effect of WPC on haematological parameters  
Groups 
RBC 
(millions/cu.mm) 
Hb 
(g/dl) 
WBC 
(103/cu.mm) 
Normal 4.54 ± 0.28 11.92 ± 0.31 9.75 ± 0.53 
EAC control 2.11 ± 0.09 6.92 ± 0.11 15.73 ± 0.36 
EAC + 200 mg of  PEEPC 3.45 ± 0.11 8.44 ± 0.96 13.31 ± 0.35 
EAC + 200 mg of EAEPC 4.08 ± 0.22 10.08 ± 0.62 11.78 ± 0.42 
EAC + 200 mg of EEPC 4.21 ± 0.72 11.22 ± 0.52 10.93 ± 0.39 
EAC + 20mg of  5- FU 4.48 ± 0.21 11.59 ± 0.17 9.67 ± 0.35 
Ø Values are expressed as mean ± S.D. (n=6) 
Table 12: Effect of WPC on Differential leukocyte count 
Groups 
Differential count (%) 
Neutrophils Lymphocytes Monocytes 
Normal 16.40 ± 0.63 81.48 ± 3.12 1.49  ± 0.11 
EAC –control (1X106 cells/ 
mouse) 
61.17 ± 2.17 35.24 ± 1.24 0.84 ± 0.03 
EAC + 200 mg of PEEPC 52.27 ± 2.31 40.92 ± 2.44 0.95 ± 0.06 
EAC + 200 mg of EAEPC 38.27 ±  2.31 53.42 ± 2.79 1.07 ± 0.06 
EAC + 200 mg of EEPC 17.04 ± 0.62 71.42 ± 2.79 1.25 ± 0.06 
EAC + 20mg of  5- FU 16.60 ± 1.97 75.11 ± 1.98 1.32 ± 0.04 
Ø Results were expressed as mean ± Standard Deviation (n=6) 
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Fig 34: Hemoglobin content of various experimental animals treated WPC 
Extracts. 
 
Fig. 35 RBC content of experimental animals treated with WPC 
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Fig: 36 White blood Cell count of various experimental animals treated with 
WPC 
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Fig: 37 Effect of Differential leukocyte count of experimental animals treated 
WPC 
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6.5.3 Lysosomal Marker enzymes,  Liver Markers, Na+/K+- ATPase and Mg+-
ATPase, Plasma glucose, Liver glycogen, DNA and RNA 
The Lysosomal Marker enzymes,  Liver Markers, Na+/K+- ATPase and 
Mg+-ATPase, glucose, glycogen, DNA and RNA levels were observed for various 
extracts of the WPC as depicted in Table 13-17 and Fig. 38-42. 
The  liver tissue was examined for the determination of lysosome specific 
cancer markers (cathepsin-D, β-D glucuronidase and acid phosphatase), liver 
marker enzymes (5’-nuclotidase and lactate dehydrogenase) and membrane bound 
ATPase (Na+/K+ ATPase and Mg2+ ATPase), plasma glucose, liver glycogen, DNA 
and RNA content. In group II mice, increase  in the activities of lysosomal marker 
enzymes, liver marker enzyme 5’-nuclotidase and decrease in the activity of Na+/K+ 
ATPase and Mg2+ ATPase were observed. Administration of EEPC and                  
5-fluorouracil restored the enzyme activities to near normal. Several studies have 
reported that flavonoids have the ability to stabilize the biological membranes of a 
cell. The restoration of lysosomal, liver marker enzymes and membrane bound 
ATPase towards normal by  various extracts of the WPC  may due to the presence 
higher amount of flavonoid. 
The levels of Plasma glucose and liver glycogen were decreased in EAC 
mice.  In  group  V  mice  (EEPC treated) and group VI (5-fluorouracil treated) the 
level of plasma glucose and liver glycogen was improved. The elevated levels of 
DNA and RNA in liver of EAC-bearing mice were strikingly decreased after 
treatment. 
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Table 13: Effect of various extracts of WPC on the activities of lysosomal 
markers enzymes in liver of normal and experimental group of animals. 
Groups 
Cathepsin-D 
(μmoles of 
tyrosine liberated 
/hr/mg protein) 
β-D-glucuronidase 
(μmoles of p-
nitrophenol 
formed/min/mg 
protein) 
Acid phosphatase 
(μmoles of Pi 
liberated/min/mg 
protein) 
Normal 
 21.73 ± 0.19 24.93 ± 0.79 3.79 ± 0.11 
EAC –control 
(1X106 cells/ 
mouse) 
41.19 ± 1.75 38.78 ± 1.25 9.14 ± 0.24 
EAC + 200 mg of 
PEEPC 33.27 ± 1.53 33.14 ± 1.17
 8.75 ± 0.80 
EAC + 200 mg of 
EAEPC 29.30 ± 1.10
 30.10 ± 0.70 6.27 ± 0.20 
EAC + 200 mg of 
EEPC 26.12 ± 1.27
 25.90 ± 0.59 4.18 ± 0.14 
EAC + 20mg of  
5- FU 22.52 ± 0.77
 24.32 ± 0.82 3.38 ± 0.09 
Ø Values expressed as mean ± S.D for 6 mice in each group. 
Table 14: Effect of various extracts of WPC on the activities of liver markers 
enzymes in normal and experimental group of animals. 
Groups 5’-nucleotidase (units/mg protein) 
Lactate 
dehydrogenase 
(units/mg protein) 
Normal 
 
2.58 ± 0.10 1.59 ± 0.10 
EAC –control (1X106 cells/ 
mouse) 
6.46 ± 0.25 0.41 ± 0.12 
EAC + 200 mg of PEEPC 5.88 ± 0.17 0.43 ± 0.53 
EAC + 200 mg of EAEPC 4.37 ± 0.16 0.48 ± 0.09 
EAC + 200 mg of EEPC 3.17 ± 0.17 1.18 ± 0.08 
EAC + 20mg of  5- FU 3.38 ± 0.16 1.25 ± 0.08
 
 
Ø Values are expressed as mean ± SEM for 6 mice in each group. 
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Table  15: Effect of various extracts of WPC on the activities of  Na+/K+- 
ATPase and Mg+-ATPase  in  liver of normal and experimental group of 
animals. 
Groups Na
+/K+- ATPase 
(units/mg protein) 
Mg+-ATPase  
(units/mg protein) 
Normal 1.88 ± 0.11 2.71 ± 0.12 
EAC –control (1X106 cells/ 
mouse) 0.93 ± 0.15 1.22 ± 0.07
 
EAC + 200 mg of PEEPC 1.06 ± 0.08 1.52 ± 0.09 
EAC + 200 mg of EAEPC 1.37 ± 0.08 2.27 ± 0.08 
EAC + 200 mg of EEPC 1.61 ± 0.08 2.58 ± 0.08 
EAC + 20mg of  5- FU 1.83 ± 0.08 2.67 ± 0.09 
Ø Values are expressed as mean ± SD for 6 mice in each group. 
Ø 1 unit   = µ moles of  pi liberated/min  
Table 16: Effect of WPC on plasma glucose and liver glycogen Levels in normal 
and experimental group of animals. 
Groups Glucose (mg/dl) Glycogen (mg/g tissue) 
Normal 
 
115.75 ± 4.93 19.81 ± 0.65 
EAC –control (1X106 cells/ 
mouse) 
49.01 ± 1.98 8.75 ± 0.51 
EAC + 200 mg of PEEPC 62.17 ± 1.73 10.17 ± 0.76 
EAC + 200 mg of EAEPC 93.14 ± 4.73 17.76 ± 0.63 
EAC + 200 mg of EEPC 107.73 ± 4.51 18.79 ± 0.59 
EAC + 20mg of  5- FU 112.33 ± 5.97 19.24 ± 0.69
 
 
Ø Values are expressed as mean ± S.D for 6 mice in each group. 
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Table 17: Effect of WPC extracts on DNA and RNA Levels in liver of normal 
and experimental group of animals. 
Groups DNA (mg/g tissue) RNA (mg/g tissue) 
Normal 
 
3.67 ± 0.15 10.85 ± 0.52 
EAC –control (1X106 cells/ 
mouse) 
7.49 ± 0.34 16.84 ± 0.67 
EAC + 200 mg of pet. Ether 
extract 
5.98 ± 0.81 14.67 ± 0.27 
EAC + 200 mg of ethyl acetate 
extract 
4.45 ± 0.17 13.14 ± 0.50 
EAC + 200 mg of Ethanol extract 3.98 ± 0.61 11.52 ± 0.59 
EAC + 20mg of  5- FU 3.72 ± 0.14 11.08 ± 0.43 
Ø Values are expressed as mean ± SEM for 6 mice in each group. 
Fig: 38  Levels of Lysosome marker in various experimental animals treated 
with WPC extracts 
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Fig: 39 levels of Liver marker in various experimental animals treated 
with WPC extracts 
 
Fig: 40  Na+/K+- ATPase and Mg+-ATPase levels of experimental animals 
treated with WPC extracts 
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Fig: 41 Glucose and Glycogen levels experimental animals treated with WPC 
extracts  
 
Fig: 42 DNA and RNA levels of various experimental animals treated with 
WPC extracts 
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6.5.4 ESTIMATION OF (TBARs) LEVEL 
The TBARs levels in the liver tissues of various experimental groups treated 
with WPC extracts are illustrated in Table 18 and Fig. 43. 
Table 18: The levels of TBARs in the liver tissues of various experimental 
groups treated with WPC extracts 
Groups Tissues TBARs 
(nmol/ml) 
Control 2.65±0.70 
EAC 4.34±0.86 
EAC + PEEPC (200mg/kg b.wt) 4.09±0.17 
EAC + EAEPC (200mg/kg b.wt) 3.78± 0.69 
EAC + EEPC (200mg/kg b.wt) 2.95 ±0.74 
EAC + 5-FC (20mg/kg b.wt) 2.89±0.49 
Ø Values are denoted as mean ± SEM  
Fig: 43 TBARs levels of experimental animals treated with WPC extracts 
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It can be observed from  table 18, and  Fig: 43 that the TBARs levels were 
high in EAC alone treated animals (group 2) than those of untreated control 
(Group1) animals. Thiobarbituric acid reactive substance (TBARs) is a product of 
LPO which is due to the oxidation of polyunsaturated fatty acids in membranes 
induced by free radicals, is an indicator of oxidative damage. Lipid peroxidation was 
enhanced in EAC bearing mice. The increased levels of lipid peroxidation were 
significantly reduced by the administration of EEPC (200mg/kg) than that of other 
extracts treated groups. 
6.5.5 ESTIMATION OF ENZYMATIC ANTIOXIDANTS 
The results of antioxidants studies like superoxide dismutase, catalase and 
glutathione peroxidase estimated in the plant extracts are tabulated in Table 19 and 
Fig. 44-46.   
Table 19: Levels of enzymatic antioxidants in experimental animals treated 
with WPC extracts  
Groups SOD (µA/ml) 
CAT 
(µB/ml) 
GPx 
(µC/ml) 
Normal 4.39 ± 0.35 24.75 ± 0.65 48.78 ± 1.70 
EAC –control (1X106 cells/ mouse) 2.52 ± 0.12 10.46 ± 0.65 28.25 ± 0.28 
EAC + 200mg of PEEPC 2.78 ± 0.13 12.78 ± 0.81 30.25 ± 0.25 
EAC + 200mg of EAEPC 3.57 ± 0.22 20.07 ± 0.64 33.47 ± 0.41 
EAC + 200mg of EEPC 3.94 ± 0.11 22.85 ± 1.21 40.25 ± 0.87 
EAC + 20mg of  5- FU 4.15 ± 0.13 23.34 ± 0.81 45.18 ± 0.66 
Ø Values are expressed as mean ± SD. 
Ø A : The amount of enzyme required to inhibit 50% nitroblue 
tetrazolium reduction;  
Ø B  :  Micromoles  of  H2O2 utilized/s; C: Micromoles of glutathione 
utilized/min. 
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Fig: 44 Levels of enzymatic antioxidant SOD in experimental animals treated 
with WPC extracts  
 
Fig: 45 Levels of enzymatic antioxidant CAT in experimental animals treated 
with WPC extracts  
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Fig: 46 Levels of enzymatic antioxidant GPx in experimental animals treated 
with WPC extracts  
 
  
It can be observed from the Table 19 and Fig 44-46 that the level of 
enzymatic antioxidant like superoxide dismutase, catalase and glutathione 
peroxidase in the tissues of EAC treated (Group 2) animals decreased significantly 
when  compared  with  Control  (Group  I)  animals.  After  administration  of  various  
extracts of WPC, in EAC treated mice especially those animals treated with 
ethanolic extract  showed an increase  in the amount of SOD, CAT and GPx in the 
liver tissues.  
6.5.6 ESTIMATION OF NON-ENZYMATIC ANTIOXIDANTS 
The results obtained for the amount of non- enzymatic antioxidants GSH, 
Vitamin C and Vitamin E present in the liver tissue of animals  treated with extracts 
of the WPC are presented in Table 20 and Fig. 47. 
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Table 20: Levels of non-enzymatic antioxidants in liver tissue treated with 
WPC extracts  
Groups Vitamin C 
(mg/g tissue) 
Vitamin E 
(mg/g tissue) 
Glutathione 
(mg/g tissue) 
Normal 2.76 ± 0.08 3.31 ± 0.13 1.93 ± 0.07 
EAC–control (1X106 cells/ mouse) 1.13 ± 0.10 1.95 ± 0.07 0.89 ± 0.22 
EAC-control + 200mg of PEPC  1.34 ± 0.10 2.09 ± 0.12 1.05 ± 0.07 
EAC + 200mg of EAEPC 2.15 ± 0.10 2.52 ± 0.12 1.39 ± 0.07 
EAC + 200mg of EEPC 2.61 ± 0.08 3.13 ± 0.16 1.68 ± 0.07 
EAC + 20mg of 5-FU 2.69 ± 0.07 3.25 ± 0.14 1.78 ± 0.07 
Ø Values are expressed as mean ± S.D. for 6 mice in each group. 
Fig: 47 Estimation of non-enzymatic antioxidants in liver tissue  
treated with WPC extracts 
 
It can be observed from the Table 20 and Fig: 47  that the amount of GSH, 
Vitamin C and Vitamin E in the liver tissue was significantly lowered in EAC alone 
treated (group 2) animals than untreated control animals. 
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 After administration of various extracts of WPC in EAC treated mice 
especially those animals treated with ethanolic extract showed an increase in the 
amount of GSH, Vitamin C and Vitamin E in the liver tissue of mice when 
compared to other extracts treated group of animals. 
6.5.7 HISTOPATHOLOGICAL STUDIES 
6.5.7.1 Histopathological changes in liver on various extracts of WPC 
Histopathological observation of liver in control and experimental group of 
mice were studied for confirming the biochemical findings (Fig. 48-53). The liver of 
normal animals showed normal hepatic cells with well preserved cytoplasm, 
nucleus, nucleolus and central vein. The liver slice of EAC mice revealed extensive 
hepatocellular lesions. In addition, hepatocytes appeared unequal in shape and nuclei 
in the cells were diffused and enlarged upon EAC inoculation.  In contrast, the 
cellular architecture and fine vacuolar of hepatocytes seemed to be almost like that 
of normal liver in group V and group VI after treatment. The size of nuclei in           
group  V  and  group  VI  was  essentially  the  same  as  that  of  normal  cells.  No  
significant alteration in the hepatic architecture   was observed in other extracts 
treated animals. 
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Fig. 48: Control liver Tissue 
 
Fig 49: EAC-induced liver tissue 
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Fig 50: EAC+ PEEPC 
 
 
Fig 51: EAC+ EAEPC 
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Fig 52: EAC+ EEPC 
 
 
Fig. 53: EAC+ Standard Drug (5FU) 
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6.6  ISOLATION OF ACTIVE PRINCIPLES FROM EEPC 
TLC Chromatographic Profiles 
Based  on  the anticancer and antioxidant activities, the EEPC was found to 
possess significant activity than other extracts. So, the EEPC was subjected to the 
TLC chromatographic profililing and column chromatographic separation.  
The EEPC dissolved  in methanol was taken in a capillary tube and spotted 
on TLC plates 2cm above its bottom. Most of the sample for application were 
between 0.1 – 1%. The applied spots were of equal size as far as possible and 
diameter ranging from 2-3mm. The solvent system for ethanolic extract was 
developed by trial and error method using various solvents which were differing in 
polarities.  
The number of spots obtained and the Rf value are given in Table. 21  
Table 21: TLC profiles of EEPC 
Separation using Column Chromatography 
The EEPC was subjected to column chromatographic separation using 
normal phase silica gel column. The dark brown solid (20g EEPC) was adsorbed on 
silica gel (20g) and transferred to a column of silica gel (200g equilibrated with n-
hexane). Elution was performed as per schedule in materials and methods. Fractions 
of 100ml were collected every time, the solvent was distilled off and the 
S.No Solvent system No. of Spots Rf Value 
1. n-hexane : Chloroform (90:10) 2 0.73, 0.36 
2. n-hexane : Chloroform (80:20) 2 0.78, 0.24 
3. n-hexane : Chloroform (70:30) 2 0.59, 0.36 
4. Ethyl acetate: Methanol (70:30) 2 0.88, 0.65 
5. Ethyl acetate: Methanol (50:50) 2 0.68, 0.47 
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homogeneity of the resulting residues was examined by TLC by using different 
solvent systems and similar fractions identified by their TLC behavior were pooled 
together. 
Qualitative chromatographic analysis of EEPC using thin layer 
chromatography was performed to separate and identify the single or mixture of 
constituents in ethanolic extract. The solvents ratio of n-hexane: chloroform (90:10) 
showed two spots (Rf values 0.73, 0.36), n-hexane: chloroform (80:20) solvent 
showed two spots (Rf values 0.78, 0.24), n-hexane: chloroform (70:30) solvent 
showed two spots (Rf values 0.59, 0.36), ethyl acetate: methanol (70:30) solvent 
showed two spots (Rf values 0.86, 0.65) and ethyl acetate: methanol (50:50) solvent 
showed two spots (Rf values 0.68, 0.47).  
The fractions 27-61 eluted with n-hexane: chloroform 70:30 v/v gave a solid 
which was designated as compound 1 (125mg). Fractions 73-95 eluted with ethyl 
acetate: methanol, 50:50 v/v gave another solid which was designated as compound 
2 (168mg). The isolated compounds were subjected to spectral analysis. The results 
obtained and the spectra are given in Figs. (54- 57) & (58- 61) respectively. 
6.7 CHARACTERISATION OF ISOLATED COMPOUNDS FROM EEPC 
6.7.1 STRUCTURE AND IDENTIFICATION OF COMPOUND 1 
The spectral data IR, 1H NMR , 13C NMR and Mass of the isolated 
compound 1 is good in agreement with the structure proposed for the compound. 
Based upon the spectral characterization data, compound 1 was found to be                   
6-methoxyflavone (molecular formula C16H12O3). 
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IR Spectrum 
The IR data of the compound 1 is analyzed from the IR spectrum (Fig.54). 
The appearance of peaks at 3062.73cm-1 and 1589.23cm-1 confirms the presence of 
Ar C-H and Ar C-C (in ring) stretching, respectively. Furthermore the appearance of 
peaks at 2923.87cm-1, 1288.35cm-1, 1674.09cm-1 and 1234.35cm-1 confirms the 
presence of CH3, ether C-O, keto C=O and C-O-C stretching, respectively.  
1H NMR Spectrum 
The 1H  NMR  data  of  the  compound 1 is analyzed from the 1H NMR 
spectrum (Fig.55). The appearance of singlet at around δ 3.9-4.1ppm shows the 
presence of OCH3. The presence of singlet at around δ 5.3-5.6ppm shows the 
presence of -CH= group. The presence of aromatic protons was observed in the 
aromatic region of 1H NMR spectra at δ 7.5-8.3, 8.5-9.3 and 9.6-10.1ppm, which 
confirms the structure. 
13C NMR Spectrum 
The 13C NMR data of the compound 1 is  analyzed  from  the  13C NMR 
spectrum (Fig.56). The appearance of peak at δ 70.04ppm in 13C NMR spectrum 
shows the presence of methoxy carbon. The presence of peaks at δ 115.26 and 
126.16ppm shows the presence of ethylene carbons. The carbonyl carbon peak was 
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observed at δ 195.98ppm. The presence of peaks at δ 128.28, 128.43, 128.51, 
128.66, 128.97, 129.01, 132.27, 133.14, 133.82, 136.51, 136.91 and 141.24 in                 
13C NMR spectrum corresponds to the aromatic carbons. 
Mass Spectrum 
The mass spectrum of the isolated compound 1 is presented in Fig.57. The 
molecular ion peak of the isolated compound 1 was found to be 252.90 (M+) which 
confirms the relative mass of the compound. 
Spectral Data of Compound 1 
IR (KBr, νmax) cm-1 1234.35 (C-O-C), 1288.35 (ether C-O), 1589.23 (Ar 
C-C {in ring}), 1674.09 (carbonyl C=O), 2923.87 (O-
CH3), 3062.73 (Ar C-H). 
1H NMR (DMSO-D6) δ 3.9-4.1 (s, 3H, O-CH3), 5.3-5.6 (s, 1H, =CH-), 7.5-8.3 
(m, 4H, Ar-H), 8.5-9.3 (d, 3H, Ar-H), 9.6-10.1 (s, 1H, 
Ar-H). 
13C NMR (DMSO-D6) δ 70.04, 115.26, 126.16, 128.28, 128.43, 128.51, 128.66, 
128.97, 129.01, 132.27, 133.14, 133.82, 136.51, 
136.91, 141.24, 195.98. 
MASS 
SPECTROSCOPY 
252.90 (M+). 
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6.7.2 STRUCTURE AND IDENTIFICATION OF COMPOUND 2 
The spectral data IR, 1H  NMR , 13C NMR and Mass of the isolated compound 
2 is in good agreement with the structure proposed for the compound. Based upon the 
spectral characterization data, compound 2 was found to be 3, 5, 7-trihydroxy-2-(4-
methoxyphenyl)-4H-chromen-4-one (Molecular Formula C16H12O6). 
 
 
 
 
IR Spectrum 
The IR data of the compound 2 is analyzed from the IR spectrum (Fig.58). The 
appearance of peaks at 3089.57cm-1 and 1617.30cm-1 confirms the presence of Ar C-H 
and Ar C-C (in ring) stretching, respectively. Furthermore the appearance of peaks at 
3612.36cm-1, 2849.32cm-1, 1291.62cm-1, 1655.41cm-1, 1220.86cm-1 and 1060.74cm1 
confirms the presence of alcoholic O-H, CH3,  ether  C-O,  keto  C=O,  C-O-C  and  
alcoholic C-O stretching, respectively.  
1H NMR Spectrum 
The 1H NMR data of the compound 2 is analyzed from the 1H NMR spectrum 
(Fig.59). The appearance of singlet at around δ 3.1-3.6ppm shows the presence of 
OCH3. The presence of broad humps at around δ 6.8-7.0 and δ 8.9-9.7ppm shows the 
presence of alcoholic O-H group. The presence of aromatic protons was observed in the 
aromatic region of 1H NMR spectra at δ 7.4-7.6, 8.1-8.2, 8.3-8.4, 8.4-8.5 and                         
8.7-8.9 ppm, which confirms the structure. 
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13C NMR Spectrum 
The 13C NMR data of the compound 2 is analyzed from the 13C NMR spectrum 
(Fig.60). The appearance of peak at δ 56.11ppm in 13C NMR spectrum shows the 
presence of methoxy carbon. The presence of peaks at δ 113.80 and 123.97 ppm shows 
the presence of ethylene carbons. The carbonyl carbon peak was observed at δ 
195.82ppm. The presence of peaks at δ 125.05, 125.36, 126.33, 126.55, 128.34, 128.89, 
129.56, 129.77, 129.84, 130.93, 131.90 and 139.48 in 13C NMR spectrum corresponds 
to the aromatic carbons. 
Mass Spectrum 
The mass spectrum of the isolated compound 2 is presented in Fig.61. The 
molecular ion peak of the isolated compound 2 was found to be 300.16 (M+) which 
confirms the relative mass of the compound. 
Spectral Data of Compound 2 
IR (KBr, νmax) cm-1 1060.74 (alcoholic C-O), 1220.86 (C-O-C), 1291.62 (ether 
C-O), 1617.30 (Ar C-C {in ring}), 1655.41 (carbonyl 
C=O), 2849.32 (O-CH3), 3089.57 (Ar C-H), 3612.36 (O-
H). 
1H NMR (DMSO-D6) δ 3.1-3.6 (s, 3H, O-CH3), 6.8-7.0 (br hump, 2H, phenolic O-
H), 7.4-7.6 (m, 1H, Ar-H), 8.1-8.2 (m, 1H, Ar-H), 8.3-8.4 
(s, 1H, Ar-H), 8.4-8.5 (s, 1H, Ar-H), 8.7-8.9 (d, 2H, Ar-H), 
8.9-9.7 (br hump, 1H, alcoholic O-H). 
13C NMR (DMSO-D6) δ 70.04, 115.26, 126.16, 128.28, 128.43, 128.51, 128.66, 
128.97, 129.01, 132.27, 133.14, 133.82, 136.51, 136.91, 
141.24, 195.98. 
MASS 
SPECTROSCOPY 
300.16 (M+). 
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6.8       In vitro antioxidant activities of isolated compounds from EEPC 
The percentage free radical scavenging of the isolated compounds namely 
compound 1 and compound 2 by different in vitro methods are presented in Table 
22. 
Table 22: DPPH scavenging potential of isolated compounds from the EEPC 
S.No 
Concentration 
(µg/ml) 
%inhibition 
Compound 1 Compound 2 
Standard 
(Rutin) 
1 125 31.07±0.24 53.51±0.03 17.75±0.45 
2 250 40.64±0.01 61.53±0.98 59.95±0.82 
3 500 52.09±0.04 74.73±0.21 63.73±0.20 
4 1000 69.94±0.18 89.83±0.78 79.84±0.19 
IC50 in µg/ml IC50=430µg/ml IC50=110µg/ml IC50=380µg/ml 
Ø *All values are expressed as mean ± SEM for three determinations 
From Table 22, it was observed that the maximum scavenging activity at 
1000µg/ml and IC50 value of compound 1 was found to be 69.94% and 430µg/ml 
respectively, and  for compound 2  it was found to be and 89.83% and 110µg/ml 
respectively, while for standard rutin, it was found to be 79.84%  and 380µg/ml 
respectively.  
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Table 23: Superoxide anion radical Inhibition potential of isolated compounds 
from the EEPC 
S.No Concentration 
 (µg/ml) 
% inhibition 
Compound 1 Compound 2 Standard 
 (Quercetin) 
1 125 45.12± 0.04 64.43± 0.39 68.85± 0.66 
2 250 56.64± 0.60 92.32± 0.18 74.81± 1.09 
3 500 76.93± 0.98 93.72± 0.05 92.90± 0.11 
4 1000 78.98± 0.12 95.93± 0.04 98.13± 1.92 
IC50 in µg/ml IC50=220µg/ml IC50=125µg/ml IC50=110µg/ml 
Ø  values are mean ± SEM for three determinations 
From Table 23, it was observed that the maximum scavenging activity at 
1000µg/ml and IC50 value of compound 1 was found to be 78.98% and 220µg/ml  
respectively, and  for compound 2 it was found to be and 95.9% and 125µg/ml 
respectively, while for standard quercetin, it was found to be 98.13%  and 110µg/ml 
respectively.  
Table 24: Nitric oxide anion radical scavenging potential of isolated compounds 
from the EEPC 
S.No Concentration 
 (µg/ml) 
% inhibition 
Compound 1 Compound 2 Standard 
 (Ascorbic acid) 
1 125 31.07± 0.24 47.37± 0.03 26.87± 0.09 
2 250 40.64± 0.01 58.36 ± 0.98 51.38± 0.08 
3 500 59.09± 0.04 62.14± 0.21 71.64± 0.43 
4 1000 69.94± 0.18 78.89± 0.78 75.23± 0.02 
IC50 in µg/ml IC50=330µg/ml IC50=180µg/ml IC50=230µg/ml 
Ø All values are expressed as mean ± SEM for three determinations 
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From Table 24, it was observed that the maximum scavenging activity at 
1000µg/ml and IC50 value of compound 1 was found to be 69.94% and 330µg/ml 
respectively and for compound 2 it was found to be and 78.89% and 180µg/ml 
respectively, while for standard ascorbic acid, it was found to be 75.23% and 
230µg/ml respectively.  
The isolated compound 2 from EEPC showed significant free radical 
scavenging activity against DPPH radical scavenging, superoxide radical scavenging 
and  nitric  oxide  radical  scavenging  methods.  Similar  result  was  not  found   for  
isolated compound 1 from EEPC. 
6.9 In vitro cytotoxicity of isolated compounds from EEPC 
The percentage growth inhibition of the isolated compounds namely 
compound 1 and compound 2 on different cell lines are presented in Table 25. 
Table 25: In vitro cytotoxicity studies of the isolated compounds from the 
ethanolic extract of WPC on different cell lines 
S. No Treatment Conc. in μg/ml 
Percentage of Inhibition 
HepG2 HT-29 
 1.  Compound 1 100 72 76 
2.  Compound 2 100 91 95 
3.  Mitomycin –C 1X10-4 88 80 
 
From table 25, it can be seen that the isolated compound 1 from the EEPC 
showed 72% and 76% growth inhibition on HepG2 and HT-29 cell lines 
respectively while the isolated compound 2 from the EEPC showed 91and 95 % 
growth inhibition. Mitomycin-C showed 88% and 80% growth inhibition on HepG2 
and HT-29 cell lines respectively. 
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The isolated compound 2 from EEPC showed  significant cytotoxicity 
against HepG2 & HT-29 cell lines. Similar result was not found for  isolated 
compound 1 from EEPC. 
6.10 P53 gene expression in HepG2 cells of isolated compound from EEPC.  
P53 gene expression was normalized to the house keeping GAPDH gene. 
The real time PCR evaluation of HepG2 cells treated with different concentrations 
of the compound 1 and 2. Compound 2 was showed in a significant dose and time 
dependent increase in p53 expression than that of compound 1. Flow cytometer 
analysis of p53 protein expression in HepG2 cells (2 × 105 cells/ml) treated with 
isolated compounds for 48h also resulted in a time and dose dependent up 
regulation of p53 when compared to control sample which confirmed the results 
from RT-PCR analysis of p53 gene expression in HepG2 cells. The real time PCR 
evaluation of HepG2 cells treated with different concentrations of the compound 2 
was showed in a significant dose and time dependent increase in p53 mRNA 
expression than compound 1.  
Table 26: Real Time PCR analysis of isolated compounds 
S.No Treatment 
Concentration (µg/ml) 
2.50 7.50 10.45 
1. Control 1.25±0.87 1.35±0.05 1.99±0.17 
2. Compound 1 3.14±0.11 4.17±1.46 6.68±0.05 
3. Compound 2 8.91±1.08 10.25±0.11 12.25±0.12 
Ø All values are expressed as mean ± SD for three determinations. 
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Fig 62: RT-PCR P53 gene expression  
 
Detection of   P53 protein expression by flow cytometry 
Fig 63: P53 protein expression in HepG2 Cells - Control 
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Fig 64: P53 protein expression in HepG2 Cells- Compound 1 
 
 
Fig 65: P53 protein expression in  HepG2 Cells- Compound 2 
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CHAPTER 7 
DISCUSSION 
For thousands of years plants have been used as food, spices and medicines. 
There are at least 250,000 plant species existing worldwide out of which more than 
1,000 plants have been found to possess anticancer activity134. The World Health 
Organization has stated that about 80% of the world’s inhabitants are dependent on 
medicinal herbal drugs for their primary health care135.  
7.1 Preliminary Phytochemical Screening 
The  Whole  Plant  of  Polycarpaea corymbosa was powdered and extracted 
with solvents of increasing polarity and were concentrated and the percentage yields 
calculated. The percentage yield obtained were 9.87%w/w, 7.88%w/w and  
16.56% w/w (Table 1) for petroleum ether, ethyl acetate and ethanol extract 
respectively. An increase in the percentage yield in a particular solvent indicates that 
more amounts of active constituents or phytoconstituents are present in that 
particular extract. 
The phytochemical screening of the Petroleum ether extract revealed the 
presence of phytosterols, fixed oils and fats. Ethyl acetate extract possess alkaloids, 
carbohydrates, glycosides, fixed oils & fat, saponin, phenolic compounds and 
tannins, protein and amino acids. The ethanolic extract contains alkaloids, 
carbohydrates, glycoside, saponins, phenolic compounds and tannins, protein and 
amino acids & flavonoids which were presented in table 2. 
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7.2  In vitro antioxidant activity  
There is a growing interest towards natural antioxidants from herbal plants 
and have been employed in protecting biomolecules against free radical mediated 
damages136-138. During the process of oxygen utilization in normal physiological and 
metabolic processes, approximately 5% of oxygen gets reduced to oxygen derived 
free radicals which are capable of attacking lipids, proteins and DNA leading to 
several diseases. An antioxidant may reduce ROS by donating hydrogen atom139. 
Relative antioxidant content provides an indication of importance of the plants. In 
general in vitro screening methods are preliminary methods which pave way for the 
in vivo evaluation140.  
7.2.1 DPPH radical scavenging activity 
DPPH (2, 2-diphenyl-1-picrylhydrazyl) is a stable free radical system, which 
is employed as an essential model by in vitro antioxidant evaluation. It accepts an 
electron or hydrogen radical to become a stable diamagnetic molecule namely 1,1- 
diphenyl – 2 – picryl hydrazine and the degree of discoloration indicates the 
scavenging activity of the drug. The percentages of DPPH radical inhibition activity 
of various extracts of WPC are presented in Table 3 and Fig. 3. All extracts tested 
possessed DPPH inhibition effect and the maximum DPPH radical scavenging 
activity of 72.02% at a concentration of 1000µg/ml and IC50 value of 225µg/ml was 
observed for the EEPC while it was 70.65% and 270µg/ml respectively for rutin. 
The IC50 value for ethanolic extracts was lesser than that of the standard which 
indicates that the extract has significant radical scavenging activity than that 
exhibited by the standard rutin.  
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7.2.2 Superoxide radical scavenging activity 
Superoxide free radical was formed by alkaline DMSO which reacts with 
nitro blue tetrazolium (NBT) to produce coloured diformazan. The extract scavenges 
superoxide radical and thus inhibits formazan formation. Superoxide radical is 
known to be very harmful to the cellular component. The percentage of superoxide 
free radical scavenging activity of various extract of WPC is presented in Table 4 
and Fig 4. All the extracts tested   possessed superoxide radical scavenging effect 
and the maximum superoxide radicals scavenging activity of EEPC was 94.41% at a 
concentration of 1000µg/ml and IC50 value of 110µg/ml while it was 89.28% and 
145µg/ml respectively for quercetin. The IC50 value for ethanolic extract was lesser 
than that of the standard which indicates that the extract has significant radical 
scavenging activity than that exhibited by the standard quercetin.  
7.2.3 Nitric oxide radical scavenging activity  
 The excessive and unregulated NO synthesis has been implicated and 
contributing to pathophysiological conditions including cancer. The various cancers 
such as cervical141, breast142, central nervous system143, laryngeal144 ,  head  and  
neck145 cancers have been detected by expression of NO. NO has been suggested to 
modulate different cancer-related events 146. However, several research have 
indicated that NO may have dual effects in cancer. In many types of clinical samples 
NO  are  measured  at  different  concentrations.  NO  seems  to  promote  tumor  growth  
and proliferation. In contrast to this, NO is said to have tumoricidal effects; various 
direct and indirect mechanisms have been proposed for its antitumor properties 147,148 
although there is lack of data directly on cancer patients. 
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 Nitric oxide was generated from sodium nitroprusside and measured by the 
greiss reagent reduction. Sodium nitroprusside in aqueous solution at physiological 
pH continuously generate nitric oxide which interacts with oxygen to produce nitrate 
ions that can be determined by use of greiss reagent. Scavengers of NO compete 
with oxygen leading to decreased production of nitric oxide. 
The percentage of nitric oxide radical scavenging activity of WPC extracts were 
presented in Table 5 and Fig 5. All the tested extracts  possessed nitric oxide radical 
scavenging effect and the maximum nitric oxide inhibition activity of 69.65% at a 
concentration of 1000µg/ml and IC50 value of 255µg/ml was observed for the EEPC 
while it was 65.23% and 410µg/ml respectively for ascorbic acid. The IC50 value of 
ethanolic extract was lesser than that of the standard which indicates that the extract 
has significant radical scavenging activity than that exhibited by the standard 
ascorbic acid.  
7.2.4 Hydroxyl radical scavenging activity 
 Hydrogen peroxide is an important reactive oxygen species because of its 
ability to penetrate biological membranes. However, it may be toxic if converted to 
hydroxyl radical in the cell149. Scavenging of H2O2 by the plant extract may be 
attributed to their phenolic compounds, which donate electron to H2O2, thus 
reducing it to water. The extract was capable of inhibiting hydrogen peroxide in a 
concentration dependent manner. 
The percentage of hydroxyl radical scavenging activity of various extract of 
WPC was presented in Table 6 and Fig  6. All the extracts tested  possessed 
hydroxyl radical inhibition effect and the maximum hydroxyl radical inhibition 
activity of 82.58% at a concentration of 1000µg/ml and IC50 value of 265µg/ml was 
observed for the EEPC respectively while it was 75.23% and 280µg/ml respectively 
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for  rutin.  The  IC50 value  of  ethanolic  extract  was  lesser  than  that  of  the  standard  
which indicates that the extract has significant radical scavenging activity than that 
exhibited by the standard rutin.  
7.2.5 Total Phenol and Flavonoid 
In vitro antioxidant studies are mostly used to screen various plant containing 
phenolic and flavonoids constituents. The phenolic and flavonoids compounds have 
received attention because of their physiological effect like anti-inflammatory, 
antioxidant, antitumor activities and low toxicity compared with such phenolic 
antioxidant butylated hydroxyl anisole, butylated hydroxyl toluene and propyl 
gallate150, 151. Phenols are very important plant constituents because of their 
scavenging ability due to their hydroxyl groups152. The phenolic compounds may 
contribute directly to antioxidative action153. Flavonoids present in food of plant 
origin are also potential antioxidants154, 155. 
The total phenolic and flavonoid content of various extract of WPC results 
was presented in Table 7 and Fig 7. All the extracts tested  possessed phenolic and 
flavonoid content. EEPC possessed the maximum of 4.60±0.05 and 3.63±0.93 
phenolic and flavonoids constituents respectively. 
Previous findings suggest that the ethanolic extract was found to have 
maximum phenolic components and which may be one the reason of it to possess 
maximum antioxidant activity than other extracts. Flavonoids play some important 
pharmacological roles against diseases, such as cardiovascular disease, cancer, 
inflammation and allergy and other oxidative stress related diseases156, 157. From the 
above discussion, it was clear that the most powerful antioxidant effect of extract is 
EEPC. 
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7.3 In vitro cytotoxicity 
The use of plant derived natural compounds as  part of herbal preparations 
and  alternative  sources  of  drugs  continues  to  play  a  major  role  in  the  wellness  of  
people  all  over  the  world158. Cytotoxicity screening models provide important 
preliminary data to help selecting plant extracts with potential antineoplastic 
properties for future work 159,160. 
MTT assay is a well-established in vitro method for cytotoxicity against 
cancer cell lines and non-cancer cell lines. The enzymes present in the cancer cells 
are capable of reducing the tetrazolium dye MTT to its insoluble formazan, which is  
purple in color161, 162.  
All the extracts of WPC tested for inhibition of growth against the following 
cell lines MCF-7, HL-60, HepG2, HT-29 and PC3 by MTT assay. From the Table 8 
and Fig: 8 and 9-28, Doxorubicin and the ethanolic extract of plant were  active on 
all the cell lines (MCF-7, HL-60, HepG2, HT-29 and PC3). The  IC50 value of 
EEPC on various cell lines are MCF-7 (6.80±0.05), HL-60 (11.50±0.45), HepG2 
(10.00±0.02), HT-29 (7.05±0.60) and PC3 (17.20±0.85). The ethyl acetate extract 
was produced moderate activity on MCF-7(28.05±0.02) cell line and inactive on HL-
60, HT-29, HepG2, and PC3 cell lines. On the other hand petroleum ether extract 
was  not  found  active  on  all  cell  lines.  The  cytotoxic  activity  might  be  due  to  the  
presence of flavonoid active component in ethanolic extract which has been proved 
by earlier studies163, 164. 
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7.4 Acute Toxicity studies 
The acute toxicity study of petroleum ether, ethyl acetate and ethanolic 
extracts of  WPC were carried out as per OECD-423 guidelines for determination of 
safe dose.  
The treatment of mice with various extracts of WPC did  not  show  any  
change in autonomic or behavioral responses.  Zero percent mortality  obtained from 
different extracts of WPC illustrated that the extracts were nontoxic upto the dose of 
2000mg/kg. Hence, there is no toxicity upto a dose of 2000mg/kg body weight of the 
animal (Table 9). 
7.5 Anticancer activity 
` The general concepts put forward by many researchers is that the anticancer 
potential of compounds which are present in plants at sub-pharmaceutical doses 
could synergize to delay or disrupt the development of aggressive disease165. Plant-
based medicine plays an important role in the treatment of cancer and 60% of 
anticancer agents which are currently used are derived from plant resources166. The 
ROS leading to oxidative stress involved in a variety of pathophysiological 
conditions including mutagenesis and carcinogenesis167. The conventional anticancer 
drugs cause non-specific killing of cells, whereas medicinal plants offer protective 
and therapeutic actions to cells with low cytotoxicity and beneficial in producing 
nutrient repletion to compromised people168, 169. Therefore, there is a need for newer 
plant derived potential chemotherapeutic agents for the management of cancer. 
In the present study, the anticancer potential of various extracts of WPC on 
EAC induced tumor in mice was monitored. The EAC induced experimental 
carcinogenesis might therefore be used as an ideal method to evaluate the 
chemopreventive potential of medicinal plant and its active constituents. 
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Oxidative damage to cellular biomolecules such as lipids, proteins and DNA 
is thought to play a crucial role in incidence of several diseases170. Flavonoids are a 
group of polyphenolic compounds found abundantly in the plant kingdom. 
Preliminary phytochemical study indicated the presence of flavonoid, alkaloids and 
tannins in EEPC whole plant. Flavonoids have been shown to possess antimutagenic 
and antimalignant effect171,172. Furthermore, flavonoids have a chemopreventive role 
in cancer through their effect on signal transduction in cell proliferation and 
angiogenesis.  
EAC  is  one  of  the  experimental  breast  tumor  derived  from  spontaneous  
mouse adenocarcinoma. Intraperitoneal injection of the tumor emulsion produces 
ascites173. A regular and rapid increase in ascitic fluid volume was observed in EAC 
bearing mice. Ascitic fluid is the direct nutritional source for tumor growth because 
it meets the nutritional requirements of tumor cells174. 
From the table 10 and Fig 29-33, Animal body weight, mean survival 
time(MST), percentage increase in life span, tumour volume, packed cell 
volume(PCV) and tumour cell count of experimental animals treated with PCE are 
presented. In the present findings body weight of mice inoculated with EAC cells 
incremented due to ascites volume proliferating peritoneal cells175. Post treatment 
with various extracts of WPC and standard drug (5-FU) significantly reduced the 
weight  gain  of  animals.  Similar  results  were  not  observed  in  animals  treated  with  
EAC alone (group II). Decreased lifespan is due to the low Hb levels observed in 
cancerous condition176. The altered levels of body weight, MST, percentage increase 
in life span, tumour volume, PCV and tumour cell count were significantly improved 
in various extracts of WPC treated groups. The change in the body weight and 
increased lifespan of animals in the treated group propose the tumor growth 
inhibitory property of the EEPC. 
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The  cytotoxicity  and  anticancer  potential  of  EEPC whole plant is probably 
due to presence of flavonoids. This present study suggests that the EEPC whole 
plant possess potent anticancer activity. 
Tumor growth is normally related with noticeable changes in haematopoiesis, 
immune response, myelosuppression and anemia177.  The alterations in the levels of 
haematological parameters namely RBC, Hb and WBC were presented in table 
11and Fig 34-36. From the table 11, it was noted that RBC count and Hb content in 
the EAC bearing mice was markedly (p<0.05) reduced whereas total WBC count 
was enhanced as compared to normal mice. The decrease in RBC and haemoglobin 
percentage maybe due to the deficiency of iron or due to the hemolytic or 
myelopathic conditions in EAC mice178 .The changes in the levels differential count 
were presented in table 12 and Fig 37. Among the various white blood cells, 
neutrophils were found to be elevated, while the lymphocytes and monocytes were 
decremented. The significant increase in WBC count and neutrophils in tumour 
bearing mice is due to its primary defense mechanism179. Supplementation of EEPC 
has  restored  WBC  count,  differential  count,  Hb  and  RBC  count  to  a  significant  
extent. No significant difference was observed between normal and plant control 
animals which evidenced the protective action of plant extract on the haematopoietic 
system. Earlier studies revealed that administration of plant extract to EAC 
inoculated mice resulted in the improved Hb and leukocytes levels180-183. The 
recoupment of  RBC, Hb, total WBC count and differential count in EAC mice with 
copper-benzohydroxamic acid complex184. 
Table 13 and Fig 38 demonstrates the effect of various extracts of WPC on 
lysosomal markers enzymes in liver of normal and experimental group of mice. 
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In  EAC  bearing  animals,  the  activity  of  cathepsin-D  was  elevated  twice  
(41.19 ± 1.75),  than the normal mice (21.73 ± 0.19). β-D glucuronidase activity was 
increased (38.78±1.25) by 56% in EAC control when compared to normal mice. The 
increase in the activity of ACP was 3-fold (9.14±0.24) when compared to normal 
animals. 
Administration of various extracts of WPC lowered the leakage of lysosomal 
marker enzymes, most likely via stabilizing the membrane architecture. This could 
be attributed to the presence of flavonoids in the extract which have an inhibiting 
property on lysosomal membranes185-187. Various extracts of WPC was found to 
stabilize the lysosomal integrity and retrieve the normal functioning of lysosomes. 
 Lysosomes are a group of cytoplasmic organelles which are characterized by 
their content of acid hydrolases that are capable of digesting the macromolecules like 
polysaccharides, nucleic acids and lipids188. The huge production of free radicals in 
the cancer leads to the irregular vulnerability of the lysosomes which results in  
elevated lysosomal enzymes189. Lysosome specific marker enzymes include 
Cathepsin–D, Acid phosphates and β-D-glucuronidase. 
Cathepsin-D plays a proteolytic role in the digestion of extracellular matrix 
(ECM) components and is implicated in tumor invasion and metastasis. Earlier 
studies reported that the Cathepsin-D plays an important role in stimulating cancer 
cells proliferation190-191 and demonstrated that transfection of rat with tumor cells 
resulted in over expression of CD. Several studies have reported the elevated 
activities of Cathepsin-D in various types of cancers192. 
β-D-glucuronidase is considered to be both a microsomal and a lysosomal 
enzyme193. They are glycosidase family of enzymes that catalyses the breakdown of 
complex carbohydrates. It is shown to be a sensitive marker of lysosomal 
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integrity194. The activity of β-D-glucuronidase depends on the rate of invasiveness of 
tumor195-196. Acid phosphatase is also a cytoplasmic enzyme that has been 
considered to be related with the lysosomes which catalyze the hydrolysis of organic 
phosphate.  
Table 14 and Fig 39 depicts the activity of liver marker enzymes  
5’-nucleotidase and lactate dehydrogenase (LDH) in normal and experimental group 
of mice. The activity of 5’-nucleotidase in EAC transplanted mice was elevated 
thrice (6.46±0.25) when compared to normal mice (2.58±0.10). Nucleotidase activity 
is increased when tumor occluding the bile ducts197. LDH activity in the liver of 
EAC inoculated mice (0.41±0.12) was markedly declined in comparison to normal 
(1.59±0.10). The decremented activity of LDH in liver was also reported by Rizk 
and Ibrahim (2008)198. On administration of various extracts of WPC and 5-FU, the 
activity was retained towards normal. No significant variation was noted between 
normal and plant control animals in the activities of 5-nucleotidase and LDH. The 
observed tumor inhibitory property of extract is impaired by the presence of 
flavonoids which possess antiproliferative action on cancer cells199. 
 5’nucleotidase is a glycoprotein having phosphatase activity. It is widely 
distributed throughout the tissues of the body and is principally localized in the 
cytoplasmic membrane of cells200. It acts on nucleoside-5’- phosphates such as 
adenosine-5’- phosphate (AMP) and adenylic acid to release inorganic phosphate. 
Lactate dehyrogenase is a tetrameric enzyme recognized as potential tumor marker 
in assessing the progression of the proliferating malignant cells. LDH enzyme is 
cytoplasmic in orgin and released into circulation after cellular damage201.                
Veena  et al., (2006)202, Walia et al., (1980)203 have reported higher activities of 
5’nucleotidase activity on various types of cancers in animal models. 
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Table 15 and Fig 40 illustrate the effect of different extracts of WPC on the 
activities of ATPases in liver of normal and experimental group of animals. When 
compared  to  normal  mice  Na+/K+-ATPase activity was decreased significantly 
(p<0.05) by 2-fold and the decrement in the activity of Mg2+-ATPase was found to 
be 56% in EAC inoculated mice. The significant decrease in the activities of Sodium 
Potassium ATPase and Magnesium ATPase in liver of cancer bearing mice may be 
due to increased production of free radicals204-205 which exerts their cytotoxic effects 
by causing peroxidation of membrane phospholipids206. Perturbation in the ion-
dependent ATPases and ion channels are seen in lipids peroxidation of membrane. 
This leads to disturbances in the ion homeostasis resulting in impaired signal 
transduction, altered cellular metabolism, changes in cell membrane permeability 
and integrity, an elevation in membrane fluidity and disturbances of vital cellular 
function207. 
   In the various extracts of WPC treated EAC-control, membrane bound 
ATPase activities were regained to a significant extent. This may be due to the 
stabilization of membranes imparted by the presence of flavonoids in the extract. 
Flavonoids influence the permeability of  biomembranes by interacting with ATPase 
pumps  in  the  animal  cell  thereby  regaining  their  normal  efficiency  and  assumed  
normal properties208.  
  Biological membranes encompass a group of ATPases which maintain ionic 
gradients between aqueous intra and extra cellular phases209. They are lipid 
dependant membrane bound enzymes and any alterations in the lipid bilayer may 
affect the activities of ATPases and inturn in normal cellular functions210. Membrane 
bound enzymes such as Sodium potassium ATPase, Magnesium-ATPase are 
responsible for the transport of sodium/potassium and magnesium across the cell 
membranes at the expense of ATP by hydrolysis211. The activities of ATPases in 
Chapter 7           Discussion 
152 
liver tissues have been shown to be inhibited in cancer bearing animals. Earlier 
studies reported that the decreased activities of membrane bound ATPases in several 
types of tumours212-213. 
The levels of plasma glucose and liver glycogen in normal and experimental 
group of mice are illustrated in table 16 and Fig 41. The level of plasma glucose 
and liver glycogen was significantly decreased in the EAC bearing mice. The 
development of hypoglycemia in experimental animals with carcinoma has been 
previously reported214-215. Numerous studies have documented hypoglycemia and 
depleted liver glycogen content in tumor bearing animals216-219.  Treatment of EAC 
mice with various extracts of WPC ameliorated the levels of plasma glucose and 
liver glycogen to a significant extent. 
Glucose is an important energy fuel in all living cells of an organism. The 
protein products of oncogene and tumor suppressor gene P53 are involved in 
stimulating the production of glycolytic enzymes. Hence, glucose uptake and 
glycolysis proceed at faster rate in tumor cells than noncancerous tissues. The high 
glycolytic rate may also result in part from smaller number of mitochondria in tumor 
cells which results in less ATP production during mitochondrial oxidative 
phosphorylation. Due to hypoxia condition experienced in cancer cells, they also 
depend on anaerobic glycolysis for much of their ATP production220. 
 Glycogen is the storage form of polysaccharide in animals. Tumor formation 
and associated increase in utilization of glucose has a way of triggering the body into 
a constant state of glycogenolysis. Increased glycogenolysis could be deduced from 
the obtained significant decrease in liver glycogen and the increased activity of 
glucose-6-phosphatase which is greatly supported by several previous findings221-223. 
Fahim et al., (2003)224 have noted that the retained levels of plasma glucose and liver 
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glycogen in solid carcinoma in after the injection of EAC mice with iodoacetate and 
dimethylsulphoxide. 
Table 17 and Fig 42 represents the effect of various extracts of WPC on the 
levels of nucleic acids in the liver of normal and experimental group of animals. In 
the EAC inoculated mice, the level of DNA was strikingly elevated by 4-fold when 
compared to normal. The increment in the levels of RNA in diseased mice was 
found to be 55% when compared to normal animals. Several studies report elevated 
levels of hepatic nucleic acids in cancerous condition225-227. Administration of EEPC 
whole plant to EAC-inoculated mice resulted in attainment of nucleic acids levels to 
near normal. No similar result was observed from other extract treated groups.  
Fahim et al., (2003)224 have reported that nucleic acid levels in liver cells of 
solid carcinoma were regained to near normal levels after the injection of EAC mice 
with iodoacetate and dimethylsulphoxide. Hussein et al., (2013)228 and Luksiene 
(2003)229 have observed the reduced levels of nucleic acid in liver cells of EAC 
control treated with antineoplastic drug and photodynamic therapy. 
Aerobic organisms are prone to free radical attacks. Nucleic acids are the 
primary target for oxidative damage which causes DNA strand breaks, chromosome 
deletions and rearrangements which results in the progression of tumor230. Abnormal 
cell proliferation is associated with the increased synthesis of nucleic acids in 
cancerous tissues. 
7.6 Level of Thiobarbituric acid reactive substance on liver tissues 
Thiobarbituric  acid  reactive  substances  (TBARs)  are  known  to  be  the  
byproducts of lipid peroxidation of polyunsaturated fatty acids present in cell 
membrane. TBARs is an indicator of oxidative damage. Elevation of Lipid 
Peroxides, as indicated by increased MDA was observed in breast cancer bearing 
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animals.231 the significant increase in LPO in carcinogenic process may be due to 
abnormal levels of ROS. ROS production in cellular antioxidant capacity may result 
in damage to protein, lipid, DNA and RNA or other effects232. 
From table 18 and Fig 43, an increase in the levels of LPO (Thiobarbituric 
acid reactive substances in liver tissue) was found in EAC induced animals. All  
extracts tested   possessed inhibition of LPO level and the significant inhibition of 
LPO was observed in EEPC at the dose 200mg/kg body weight. 
Thiobarbituric acid reactive substances, which are markers of lipid 
peroxidation were found to be decreased, suggesting decreased levels of oxygen free 
radicals due to their increased quenching or scavenging233 by the increased levels of 
antioxidants . EEPC at  the  dose  200mg/kg  body  weight  proved  to  be  an  efficient  
antioxidant in in-vivo system. 
7.7 In vivo antioxidant studies 
Elevated oxidative stress can change a number of cellular targets and cause 
cell damage and the subsequent lack of repair has been responsible for 
carcinogenesis234. The natural antioxidants have wide variety of biochemical 
activities, including inhibition of ROS generation, scavenging of free radicals by 
directly or indirectly and changing of anti-oxidant potential235. The antioxidant 
enzymes such as catalase, superoxide dismutase and glutathione peroxidase are 
present in oxygen handling cells which are the first line cellular defense against 
oxidative injury and decomposes O2 and  H2O2 before they interact to form more 
reactive radicals236. Superoxide dismutase detoxifies the O2- to H2O2, which has been 
removed by Catalase. The results for enzymatic antioxidants SOD, CAT and GPx 
obtained are presented in table 19, Fig 44-46. 
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7.7.1 Superoxide Dismutase 
McCord and Fridorich described that the metalloenzyme superoxide 
dismutase237. SOD act as an anti-carcinogen inhibitor during the initiation and 
promotion stages of carcinogensis238 Superoxide dismutase plays an important role 
in catalyzing the dismutation of superoxide radicals and increase in SOD activity 
accelerates the removal of the ROS. Superoxide dismutase is the major intracellular 
antioxidant enzyme, which is essential for the survival of aerobic cells. It 
catalytically scavenges the superoxide radical, which appears to be an important 
agent for toxicity of oxygen and thus provides a defense against oxygen toxicity. 
In the present study, decline in SOD level was observed in EAC induced 
mice which may be due to the increase in circulating lipid peroxides which results in 
accumulation of superoxide anion, a highly diffusible and potent oxidizing radical 
capable of traversing membranes causing deleterious effects at sites far from the 
tumor. From table 19 and Fig 44, all the extracts significantly increased the SOD 
level towards normal. Among the different extracts, Ethanolic extract showed better 
and effective result.  
7.7.2 Catalase 
Catalase is an enzyme present in the cells of animals, plants and aerobic 
bacteria239. Catalase is located in a cell organelle called peroxisome. In animals 
catalase is present in all major body organs. The role of catalase is to scavenge 
hydrogen peroxide and prevent oxidative damage in the cancerous cell240. CAT and 
GPx  detoxify  significant  amount  of  H2O2 are produced during electron transport 
chain and protect mitochondrial membranes from lipid peroxidative damage. The 
enzymatic antioxidant catalase is widely distributed in all tissues and catalyses the 
breakdown of hydrogen peroxide produced by tumor cells.  
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Decrease in the activities of the antioxidant enzyme catalase level was noted 
in the EAC induced tumor group which is regarded as a marker of malignant 
transformation241 . In the present study, decline in catalase level was observed in 
EAC induced mice. From the table 19 and Fig 45, all the tested extracts  possessed 
increased  CAT level and significant improvement in CAT was observed in EEPC 
when compared to other extracts.  
7.7.3 Glutathione Peroxidase 
GPx is an important defense enzyme against oxidative damage and this in 
turn requires glutathione as a cofactor242. Several studies have reported the decreased 
activities of GPx in various cancerous conditions. There was a decline in the 
activities of GPx which may be due the altered antioxidant defense system caused by 
enormous production of free radicals in EAC-induced carcinogenesis. 
In the present study, a decrease in GPx level was observed in EAC induced 
mice. From table 19 and Fig 46, all the tested extracts possessed increased GPx 
level when compared to tumour induced animals and a significant improvement in 
GPx was observed in the EEPC treated animals. The increased level of enzymatic 
antioxidant superoxide dismutase, catalase and glutathione peroxidase seen after 
treatment of extracts of WPC may be either due to enhanced activity because of 
antioxidant potential. 
7.7.4 Glutathione ,Vitamin  C and Vitamin E 
Cancer cells may sequester essential antioxidants from circulation to supply 
the  demands  of  growing  tumor.  Apart  from  the  enzymatic  antioxidants,  non-
enzymatic antioxidants such as GSH, Vitamins C and E play an excellent role in 
protecting the cells from oxidative stress 243-248. The non-enzymatic antioxidant 
systems are the second line of defense against free radical damage.  
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 In  the  present  study,  a  decrease  in  the  GSH,  Vitamin  C  and  E  level  was  
observed in EAC induced mice. From the table 20 and Fig 47, All the extracts 
tested  possessed increased activity of non enzymatic antioxidants like GSH, vit.C 
and vit.E level in the liver tissue of control. A significant improvement was observed 
in the EEPC at the dose of 200mg/kg body weight when compared to other extracts. 
Increased amount of vitamin C and E present in animals treated with EEPC 
(200mg/kg body weight) could be attributed  to increased uptake or availability at 
the site itself . 
7.8 Histopathology 
The antitumor activity was further confirmed by histopathological findings.  
When the cells are exposed to chemical carcinogens or radiation, changes are most 
prominent at cellular and tissue levels which are usually reflected in the 
histopathological architecture. Histopathological examination of liver in control and 
experimental group of mice were evaluated for conforming the biochemical findings 
(Fig 48-53). The liver of normal animals showed normal hepatic cells with well 
preserved nucleus, nucleolous, cytoplasm and central vein. The liver slice of EAC 
mice exposed extensive hepatocellular lesions. In addition, hepatocytes appeared as 
irregular shape and nuclei in the cells were diffused and enlarged upon EAC 
inoculation. 
In contrast, the cellular architecture and fine vacuolar of hepatocytes seemed 
to be almost similar to that of normal liver in group III and group IV after treatment. 
The size of nuclei in group V and group VI (Fig 52-53) was basically the same as 
that of normal cells and also no significant alterations in the hepatic architecture of 
other extract treated groups were observed. Chakraborty et al., (2007)249 have 
reported the alterations in the liver of EAC transplanted mice. Bairy et al., (2003) 250 
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have demonstrated that intraperitoneal injection of vincristine to EAC bearing mice 
resulted in the reduction of neoplastic lesions in the hepatocytes. 
7.9 Isolation and Characterization of active principle from EEPC 
Based  on  the anticancer and antioxidant activities, the EEPC was found to 
possess significant activity than that of the other extracts. So, the EEPC was 
subjected to the TLC chromatographic profiling and column chromatographic 
separation. The number of spots obtained and the Rf value are given in Table. 21. 
EEPC was introduced in the column and eluted with gradation of solvents,, 
the fraction 27-61 eluted with n-hexane: Chloroform (70:30 v/v) gave a solid which 
was designated as compound 1 (125mg). Fractions 73-95 eluted with ethyl acetate: 
methanol (50:50 v/v) gave another solid which was designated as compound 2 
(168mg).  
The results obtained and the spectra are given in Figs. 54-61. The structure 
and identification of isolated compound was done using FT-IR, 1HNMR,  13CNMR 
and Mass spectroscopic techniques. As per the spectral analysis, the structure of 
compound 1 is proposed to be 6-methoxyflavone and its molecular formula was 
deduced as C16H12O3; Compound 2 was proposed to be 3,5,7-trihydroxy-2-(4-
methoxyphenyl)-4H-chromen-4-one and its molecular formula was deduced as 
C16H12O6.  
7.10 In vitro antioxidant activities of isolated compounds from WPC 
 The in vitro antioxidant studies of isolated compounds from WPC were 
evaluated by DPPH scavenging, superoxide radical scavenging and nitric oxide 
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scavenging methods.  The isolated compound 2 from EEPC showed a significant 
free radical scavenging activity against DPPH radical scavenging, superoxide radical 
scavenging and nitric oxide radical scavenging methods than compound 1. The 
results obtained are presented in Table 22-24. 
The phenolic compounds may contribute directly to antioxidative action. 
Flavonoids present in food of plant origin are also potential antioxidants. The 
phenolic and flavonoids compounds have received attention because of their 
physiological effect like anti-inflammatory, antioxidant, antitumor  activities and 
low toxicity compared with such phenolic antioxidants  butylated hydroxylanisole, 
butylated hydroxytoluene and propyl gallate.  
7.11 In vitro cytotoxicity of isolated compounds from WPC 
The isolated compounds from WPC were evaluated for in vitro cytotoxicity 
studies against the following cell lines HepG2 & HT-29 by MTT- assay. The 
isolated compound 2 from EEPC showed a significant cytotoxicity effect against 
HepG2 & HT-29 cell lines than compound 1. The results obtained are presented in 
Table 25. Previous studies suggested that all the fractions of isolated compound 
have direct relationship with tumor cells. Tumor cells absorb the anticancer drug by 
direct absorption in target tissue and this anticancer agent may lysis the cell by direct 
cytotoxic mechanism. 
7.12 P53 gene expression in HepG2 cells of isolated compounds  
P53 is a significant tumor suppressor gene and its mutations are among the 
most frequent genetic alterations detected in different kinds of human cancers251, 252. 
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The real time PCR evaluation of HepG2 cells treated with different concentrations of 
isolated compounds. The expression of p53 was found to be upregulated in isolated 
compounds when compared with control. Compound 2 showed in a significant dose 
and time dependent increase in p53 expression than compound 1. Flow cytometer 
analysis of p53 protein expression in HepG2 cells treated with isolated compounds, 
compound 2 was showed in a significant increase in p53 mRNA expression than 
compound 1. The compound 2 could induce cytotoxic and genotoxic activities on 
human hepatocellular carcinoma (HepG2) cells through induction of apoptotic 
pathway. 
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CHAPTER- 8 
SUMMARY AND CONCLUSION 
Plant-based medicine plays a vital role in cancer management and 60% of 
currently used anticancer drugs are derived from plant resources.    
In the present investigation, entitled “Study on anticarcinogenic activity of 
Indian medicinal plant-Polycarpaea corymbosa. Lamk”, the  whole  plant  of  
Polycarpaea corymbosa was screened for anticancer activity.  
The dried powder of WPC was extracted sequentially using different 
polarities of solvents like petroleum ether, ethyl acetate and ethanol. The EEPC had 
the highest yield (16.56%) when compared to other extracts. 
The phytochemical screening revealed the presence of phytosterols, fixed oils 
and fats in PEEPC. In EAEPC, alkaloids, carbohydrates, glycosides, fixed oils and 
fats, saponins, phenolic compounds, tannins, protein and amino acid were present. 
The EEPC containins alkaloids, carbohydrates, glycoside, saponins, phenolic 
compounds, tannins, protein and aminoacid & flavonoids. 
The extracts were subjected to in vitro antioxidant studies.The extracts were 
tested for their activities against DPPH, nitric oxide, hydroxyl, super oxide radicals. 
All the extracts tested  possessed antioxidant activity. The present findings indicated 
that EEPC exhibited significant antioxidant activity by inhibiting DPPH , nitric 
oxide radical, hydroxyl radical and super oxide anion radical scavenging activities. 
In addition, all the extracts were estimated for the total phenolic and flavonoid 
content. EEPC was found to contain a noticeable amount of phenolics and 
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flavonoids  than  other  extracts  and  hence  play  a  major  role  in  controlling  oxidative  
stress.  
The various extracts of  WPC were subjected to in vitro cytotoxic activity 
on MCF-7, HL-60, HepG2, HT-29 and PC3 cell lines. The ethanolic extract of plant 
extract was active on all cell lines (MCF-7, HL-60, HepG2, HT-29 and PC3). The 
cytotoxic activity might be due to the presence of flavonoids active component in 
EEPC. 
The acute toxicity study  of  various  extracts  from WPC was  carried  out  as  
per OECD 423 guidelines for safe dose administration to animals. There was no 
toxicity up to a dose of 2000mg/kg body weight of the animal and did not cause any 
death of  tested animals. 
The various extracts of WPC were subjected to in vivo anticancer study. 
The altered levels of animal body weight, mean survival time, percentage increase in 
life span, tumour volume, packed cell volume, tumour cell count, RBC, Hb,  WBC, 
differential count, cathepsin-D, acid phosphatase, β-D-glucuronidase,  
5’ nucleotidase, lactate dehyrogenase, Na+/K+-ATPase, Mg2+-ATPase, plasma 
glucose,  liver  glycogen  and  Nucleic  acids  (DNA  &  RNA)   were  significantly  
improved with administration of the various extracts of WPC. 
The levels of thiobarbituric acid reactive substances (TBARs) in the tissues 
were significantly reduced after the treatment with extracts of WPC. The enzymatic 
antioxidants and  non enzymatic antioxidants were significantly improved after  
treatment with extracts of  WPC, which are decreased in cancerous conditions as 
seen in EAC alone treated animals. The EEPC at a dose of 200mg/kg body weight 
showed significant improvement of all the altered levels induced EAC and also 
showed maximum reduction of TBARs levels while enzymatic antioxidants like 
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superoxide dismutase, catalase, glutathione peroxidase and the level of non 
enzymatic antioxidants like GSH, vitamin C and E in the liver tissue were 
significantly improved when compared with other extracts. The in vivo study 
indicates that the plant extracts are a significant source of natural antioxidant, which 
might be useful in preventing different types of oxidative stresses. The flavonoids 
present in the ethanolic extract may be responsible for this anticancer effect. 
Histopathological studies in liver cells shows carcinoma of the mice liver 
with extensive hepatocellular lesions, unequal shape of hepatocytes and enlarged 
cells in EAC alone induced mice (Group II). The PEEPC and EAEPC treated 
(Group III -IV) animals showed mild changes in cellular architecture and shape of 
the hepatocytes.  The EEPC treated animals (Group V) and standard drug treated 
animals (Group VI) showed the cellular architecture and fine vacuolar of hepatocytes 
similar to the normal animals. 
The present study has shown that the EEPC has significant anticancer 
activity which was confirmed by in vitro cytotoxicity studies and in vivo anticancer 
studies.  
Isolation and characterization of active compounds 
The ethanolic extract containing phenolic compounds and flavonoids which 
showed significant in vivo anticancer potential formed the basis for isolation of 
phytoconstituents by column chromatography. Two compounds were isolated from 
the EEPC namely, 6- methoxyflavone (compound 1) and 3, 5, 7-trihydroxy-2-(4-
methoxyphenyl)-4H-chromen-4-one (compound 2).These two compounds were 
characterized by IR, 1H NMR, 13C NMR and GC MS. The isolated compounds from 
EEPC were subjected to in vitro antioxidant (DPPH, superoxide radical scavenging 
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and nitric oxide scavenging activity)  and  in vitro cytotoxic activity using cell lines 
human colon cancer cell line (HT29) and  human cancerous liver cell line (HepG2).   
The isolated compound from EEPC (compound 2) showed  significant 
antioxidant and cytotoxicity properties. Similar results were not seen with isolated 
compound 1.  
The isolated compounds from ethanolic extract of WPC were subjected to 
P53 gene expression in HepG2 cells. The real time PCR evaluation of HepG2 cells 
treated with different concentrations of the isolated compounds. The compound 2 
was showed in a significant dose and time dependent increase in p53 expression than 
that of compound 1.  Flow cytometer study of p53 expression in HepG2 cells (2 × 
105 cells/ml) treated  isolated compounds produced time and dose dependent increase 
in p53 mRNA expression when compared to control which confirmed the results 
from q-PCR analysis of p53 gene expression in HepG2 cells. The compound 2 was 
showed significant effect than compound 1.The compound 2 could induce cytotoxic 
and genotoxic activities on human hepatocellular carcinoma (HepG2) cells.  
              These findings from the biochemical basis for the use of compounds from 
WPC as anticarcinogenic, at least in part, through modulation of apoptosis. 
Furthermore, in vivo studies are needed to investigate the possible mechanism of 
action of isolated compounds derived from the plant against cancer.	
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CHAPTER 9 
IMPACT OF THE STUDY 
v This finding provides some biochemical basis for the use of compounds from 
Polycarpaea corymbosa as anticarcinogenic, at least in part, through modulation 
of apoptosis.  
v Effectiveness along with safety of the isolated compound will form the basis of 
the future choice of this drug in cancer treatment. 
v Polycarpaea corymbosa may be ingested more frequently in different forms, if 
not to treat cancers, then as a prophylactic against them.  
v Furthermore, in vivo studies are needed to explore the possible mechanism of 
action of isolated compounds derived from the plant against carcinoma. 
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